Bronchitis, not specified as acute or chronic

J10_BRONCH

bronchitis: An acute or chronic inflammatory process affecting the bronchi. [database_cross_reference: NCIT:C2911]

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J40 Hospital discharge: ICD-9 — 490 Hospital discharge: ICD-8 — 49099 Cause of death: ICD-10 — J40 Cause of death: ICD-9 — 490 Cause of death: ICD-8 — 49099 2 out of 7 registries used, show all original rules.	4331
4. Check minimum number of events None	4331
5. Include endpoints None	4331
6. Filter based on genotype QC (FinnGen only)	3913

Control definitions (FinnGen only)

Control exclude: J10_LOWCHRON

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: J40-J47
Name in latin: Bronchitis non specificata utrum acuta an chronica

NAME	J10_BRONCH
CONTROL_EXCLUDE	J10_LOWCHRON
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J40
HD_ICD_9	490
HD_ICD_8	49099
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J40
COD_ICD_9	490
COD_ICD_8	49099
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bronchitis, not specified as acute or chronic based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	45745	19996	25104
Only index persons	31269	13713	17556
Unadjusted period prevalence (%)
Whole population	0.64	0.57	0.70
Only index persons	0.60	0.50	0.67
Median age at first event (years)
Whole population	42.04	52.72	33.02
Only index persons	30.35	43.02	20.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3913	1781	2132
Unadjusted period prevalence (%)	0.82	0.63	0.98
Median age at first event (years)	35.38	40.11	31.43

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4023: Matched controls
40225

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

49300

ICD-8 Finland

Asthma, bronchiale

+∞

322.3

305

R03AK08

ATC

formoterol and beclometasone; inhalant

20.1

310.3

241

127

H02AB06

ATC

prednisolone; systemic

3.4

309.6

2251

11024

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

35.1

307.7

556

183

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

68.9

307.7

178

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

80.7

307.7

299

4900A

ICD-9 Finland

Bronchitis, not specified as acute or chronic[BRONCHITIS NUD]

+∞

307.7

679

R03AK06

ATC

salmeterol and fluticasone; inhalant

10.1

307.7

895

1109

R03BA02

ATC

budesonide; inhalant

7.1

307.7

1049

1904

J45.0

ICD-10 Finland

Predominantly allergic asthma

70.0

307.7

556

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

78.1

307.7

1494

302

R03AC12

ATC

salmeterol; inhalant

51.2

307.7

368

R03DA04

ATC

theophylline; systemic, rectal

16.0

307.7

403

278

R03AK07

ATC

formoterol and budesonide; inhalant

4.3

307.7

1087

3161

R03AC02

ATC

salbutamol; inhalant

4.6

307.7

2687

12152

R03DC03

ATC

montelukast; oral

6.8

307.7

911

1661

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

47.4

307.7

245

R96

ICPC

Asthma

14.5

307.7

508

396

R03BA05

ATC

fluticasone; inhalant

5.8

307.7

1010

2188

J46

ICD-10 Finland

Status asthmaticus

111.3

307.7

201

J45.8

ICD-10 Finland

Mixed asthma

176.2

307.7

201

R03AC03

ATC

terbutaline; inhalant

5.6

307.7

735

1542

J45

ICD-10 Finland

Asthma

13.8

307.7

540

446

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

+∞

307.7

1354

R03BA01

ATC

beclometasone; inhalant

7.1

307.7

777

1310

J45.1

ICD-10 Finland

Nonallergic asthma

122.4

307.7

437

R03BB04

ATC

tiotropium bromide; inhalant

21.0

307.7

672

381

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

129.9

307.7

186

J45.9

ICD-10 Finland

Asthma, unspecified

29.3

307.7

1207

580

R03AC13

ATC

formoterol; inhalant

20.5

307.7

297

156

49099

ICD-8 Finland

Bronchitis, unspecified

+∞

307.7

1923

R03BB01

ATC

ipratropium bromide; inhalant

12.8

295.0

293

245

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

3.7

276.2

1142

3899

R03AK03

ATC

[U] fenoterol and ipratropium bromide

9.3

275.1

346

405

R03BA08

ATC

ciclesonide; inhalant

5.9

209.1

399

735

H02AB04

ATC

methylprednisolone; systemic

3.7

206.9

762

2369

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

10.4

183.6

207

208

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

6.7

181.7

299

474

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.7

180.7

1351

6284

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.8

180.6

439

998

J01FA06

ATC

roxithromycin; oral

2.5

174.5

1799

9740

J47

ICD-10 Finland

Bronchiectasis

356.1

171.6

172

XG474

NOMESCO Finland

Exhalation nntrogen oxide

13.5

152.3

144

110

H02AB07

ATC

prednisone; oral

3.3

152.1

661

2257

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

148.9

142

J01AA02

ATC

doxycycline; systemic

2.8

148.0

3253

24129

R95

ICPC

Chron obstructive pulmonary disease

16.7

139.2

117

R06.0

ICD-10 Finland

Dyspnoea

2.5

139.0

1181

5727

48609

ICD-8 Finland

Pneumonia, unspecified

8.6

131.9

171

206

XG410

NOMESCO Finland

Flow-volume spirometry

6.6

130.2

216

344

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

127.8

122

J01MA14

ATC

moxifloxacin; systemic

3.5

126.1

474

1469

38100

ICD-8 Finland

Otitis media without mention of mastoiditis, Acute

6.0

118.6

215

374

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

6.8

116.7

187

287

R03DC01

ATC

zafirlukast; oral

17.7

116.4

R02

ICPC

Shortness of breath/dyspnoea

3.0

115.1

586

2174

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

7.6

113.8

163

221

R03AK11

ATC

formoterol and fluticasone; inhalant

12.9

109.5

106

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

7.1

106.5

163

238

J42

ICD-10 Finland

Unspecified chronic bronchitis

19.7

104.4

R06.2

ICD-10 Finland

Wheezing

5.2

103.8

219

438

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

30.1

102.9

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

100.6

470

1655

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

98.0

1939

12775

R05

ICD-10 Finland

Cough

2.3

95.1

917

4600

J01MA12

ATC

levofloxacin; systemic

2.3

92.5

838

4088

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

91.1

2079

14257

J96.1

ICD-10 Finland

Chronic respiratory failure

9.3

90.9

110

121

R03BC01

ATC

cromoglicic acid; inhalant

12.1

90.2

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.4

89.6

349

1099

1240

FHL

Bronchoscopy

9.3

89.2

108

119

R03BC03

ATC

nedocromil; inhalant

3.6

87.3

307

905

J43.9

ICD-10 Finland

Emphysema, unspecified

34.2

84.9

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

12.0

84.2

J01FA10

ATC

azithromycin; systemic

1.9

83.7

2177

15423

48509

ICD-8 Finland

Bronchopneumonia, unspecified

7.8

83.3

116

152

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.1

81.7

231

584

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

18.3

81.2

R04.2

ICD-10 Finland

Haemoptysis

4.7

79.6

190

421

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.8

79.2

432

1648

R06AE07

ATC

cetirizine; oral

1.9

77.9

1648

10850

R05

ICPC

Cough

2.1

77.7

975

5372

J01FA09

ATC

clarithromycin; systemic

2.0

76.8

1201

7152

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

76.3

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

5.0

75.2

164

337

J20

ICD-10 Finland

Acute bronchitis

2.7

73.7

448

1805

N02AX02

ATC

tramadol; systemic, rectal

1.8

73.4

1736

11774

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

72.9

1933

13564

R01AD08

ATC

fluticasone; nasal

2.0

71.7

1086

6372

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

71.0

951

5343

Y0499

ICD-8 Finland

Investigation of respiratory system

8.8

70.7

103

R01AD09

ATC

mometasone; nasal

1.8

67.1

1669

11403

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

3.0

66.4

304

1051

C03CA01

ATC

furosemide; systemic

1.9

65.7

1252

7879

R03BB02

ATC

oxitropium bromide; inhalant

20.2

65.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.9

64.8

977

5693

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

10.6

63.0

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

11.8

62.8

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

59.6

194

541

XG405

NOMESCO Finland

Education on PEF monitoring

9.7

59.3

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

58.6

1086

6733

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

58.5

SPAT1059

SPAT

Spirometry at the office

3.8

58.1

180

485

XQ800

NOMESCO Finland

Prick test

3.1

58.1

256

864

N03AX16

ATC

[U] pregabalin

1.9

57.7

896

5248

R05FB02

ATC

cough suppressants and expectorants; systemic

1.7

57.5

1411

9491

J01DA01

ATC

[U] cefalexin

1.7

57.5

2378

18432

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

123.8

57.0

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.8

56.0

1029

6349

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

23.8

55.7

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

5.0

54.9

119

243

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

54.3

J01CA04

ATC

amoxicillin; systemic

1.8

54.3

3103

26100

50099

ICD-8 Finland

Hypertrophy of tonsils and adenoids

2.3

52.5

431

1984

R05CB01

ATC

acetylcysteine; inhalant, oral

6.6

51.9

130

R05FA02

ATC

opium derivatives and expectorants; systemic

1.7

49.9

1452

10137

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

49.3

1086

7026

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

10.5

49.1

SPAT1058

SPAT

PEF monitoring instruction

2.8

48.8

252

928

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

20.7

48.7

J41.0

ICD-10 Finland

Simple chronic bronchitis

15.0

48.5

J01FA15

ATC

telithromycin; oral

2.4

48.3

373

1670

R29

ICPC

Respiratory symptom/complaint other

2.7

48.2

277

1079

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

48.0

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

4.7

47.4

112

246

A02BC03

ATC

lansoprazole; oral

1.7

47.0

1060

6886

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

46.8

573

3075

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

46.0

722

4210

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.7

46.0

147

405

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

45.9

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.4

45.2

116

272

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.0

45.0

205

705

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

44.9

1090

7213

A02BC02

ATC

pantoprazole; systemic

1.6

44.5

2554

20846

R81

ICPC

Pneumonia

3.3

44.3

172

538

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.5

44.1

154

450

46599

ICD-8 Finland

Acute upper respiratory infection of multiple or unspecified sites

2.5

44.1

297

1249

R51.80

ICD-10 Finland

Headache

1.9

43.8

594

3298

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

43.1

1345

9473

J01DA06

ATC

[U] cefuroxime

2.0

43.1

534

2873

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

42.8

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

42.8

A02BA02

ATC

ranitidine; systemic

1.8

42.7

742

4454

GD1AD

NOMESCO Finland

Thorax CT examination

2.7

41.9

243

950

R01AD05

ATC

budesonide; nasal

2.5

41.6

274

1140

J01FA01

ATC

erythromycin; systemic

2.0

41.5

510

2733

N06AB04

ATC

citalopram; systemic

1.8

41.1

784

4833

A02BC01

ATC

omeprazole; systemic

1.7

41.0

1009

6675

A02BC05

ATC

esomeprazole; systemic

1.6

40.9

1474

10714

G47.3

ICD-10 Finland

Sleep apnoea

1.7

40.7

874

5569

R01AD12

ATC

fluticasone furoate; nasal

1.7

40.6

1073

7228

R03CC02

ATC

salbutamol; systemic

3.2

39.8

161

516

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

6.2

39.4

109

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

39.2

409

2064

I50.9

ICD-10 Finland

Heart failure, unspecified

1.9

37.4

573

3299

M03BX02

ATC

tizanidine; oral

1.5

37.2

2256

18284

J01DB01

ATC

cefalexin; oral

1.6

36.9

3118

27210

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

5.1

36.9

156

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.5

36.8

243

1011

J01FF01

ATC

clindamycin; systemic

1.6

36.6

984

6629

49309

ICD-8 Finland

Asthma, Unspecified

+∞

36.5

3820A

ICD-9 Finland

Suppurative and unspecified otitis media, Acute suppurative otitis media

6.1

36.2

105

7860A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Dyspnoea and respiratory abnormalities[DYSPNOEA]

7.4

36.0

R06AX22

ATC

ebastine; oral

1.8

35.9

577

3367

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

35.8

718

4471

SPAT1257

SPAT

Teaching of medicine inhalation technique

4.0

35.7

103

264

51899

ICD-8 Finland

Bronchiectasis

+∞

35.5

R01AD58

ATC

fluticasone, combinations; nasal

1.7

35.4

843

5499

A07AA02

ATC

nystatin; oral

2.6

35.3

218

879

R06AX27

ATC

desloratadine; oral

1.6

35.2

936

6277

A01AB09

ATC

miconazole; local oral

2.2

35.2

302

1409

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

35.2

272

1215

78310

ICD-8 Finland

Symptoms referable to respiratory system, Haemoptysis

14.0

34.8

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

34.3

945

6389

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

34.2

815

5312

C07AB07

ATC

bisoprolol; oral

1.5

34.1

1767

13756

50709

ICD-8 Finland

Hay fever, Unspecified

7.8

34.0

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

5.9

33.9

105

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.6

33.7

116

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

33.7

372

1913

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

33.5

495

2811

J01MA02

ATC

ciprofloxacin; systemic

1.5

33.2

1443

10807

SPAT1254

SPAT

Administration of medicine

1.8

33.0

533

3110

49308

ICD-8 Finland

Asthma, Alia definita

+∞

32.3

R01AD11

ATC

triamcinolone; nasal

2.2

32.3

304

1472

J02AC01

ATC

fluconazole; systemic

1.5

32.2

1246

9087

J01DA09

ATC

[U] cefadroxil

1.6

32.2

943

6456

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

32.0

289

1376

R50.9

ICD-10 Finland

Fever, unspecified

1.8

31.6

578

3496

R03DA05

ATC

aminophylline; systemic, rectal

8.9

31.6

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

5.1

31.2

132

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

30.9

303

1490

M54.5

ICD-10 Finland

Low back pain

1.5

30.9

1308

9709

R06AX13

ATC

loratadine; oral

1.8

30.5

477

2753

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.4

30.4

208

880

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

5.5

30.0

107

R42

ICD-10 Finland

Dizziness and giddiness

1.6

29.9

842

5697

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

29.8

439

2487

A03FA02

ATC

cisapride; oral, rectal

2.1

29.5

285

1393

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.0

29.5

357

1895

E0000UV, ,

ATC

1.5

29.4

1441

10994

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

29.3

454

2610

49101

ICD-8 Finland

Chronic bronchitis, Nonpurulenta (simplex)

+∞

29.2

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

29.2

UJF32

NOMESCO Finland

Coloscopy

1.6

29.1

905

6263

N06AX21

ATC

duloxetine; oral

1.9

29.1

425

2400

M79.6

ICD-10 Finland

Pain in limb

1.5

29.1

1538

11904

J37.0

ICD-10 Finland

Chronic laryngitis

3.1

29.1

126

421

P01AB01

ATC

metronidazole; oral, rectal

1.5

28.8

1348

10181

N03AX12

ATC

[U] gabapentin; oral

1.7

28.7

554

3398

SPAT1263

SPAT

Sampling

1.5

28.5

1425

10899

R74

ICPC

Upper respiratory infection acute

1.5

28.1

1082

7838

N05BA04

ATC

oxazepam; oral

1.6

28.0

941

6618

R01AD01

ATC

beclometasone; nasal

1.8

27.9

495

2961

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

27.8

1551

12097

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

27.8

772

5195

A03

ICPC

Fever

1.7

27.6

596

3765

N05BA01

ATC

diazepam; systemic, rectal

1.8

27.6

472

2794

N06AA09

ATC

amitriptyline; systemic

2.0

27.4

336

1790

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

27.4

619

3958

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.4

27.4

191

815

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

27.4

906

6348

R53

ICD-10 Finland

Malaise and fatigue

1.5

27.2

931

6570

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

27.2

994

7115

R78

ICPC

Acute bronchitis/bronchiolitis

3.9

27.2

204

7862A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Cough

6.7

26.7

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

26.7

1172

8708

L28

ICPC

Limited function/disability (L)

1.6

26.6

673

4425

TGC00

NOMESCO Finland

Bronchial lavation

3.4

26.5

278

R03AL11

ATC

formoterol, glycopyrronium bromide and budesonide; inhalant

34.3

26.5

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.7

26.5

483

2912

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

26.3

1513

11836

R52.9

ICD-10 Finland

Pain, unspecified

1.9

26.3

375

2100

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

26.1

XG466

NOMESCO Finland

Sleep oxymetry

3.1

26.1

109

357

J33.0

ICD-10 Finland

Polyp of nasal cavity

3.2

25.5

102

325

R13

ICD-10 Finland

Dysphagia

2.1

25.5

260

1297

R03AC04

ATC

fenoterol; inhalant

58.4

25.0

C01DA14

ATC

isosorbide mononitrate; oral

1.6

24.9

598

3877

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

24.8

165

689

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.4

24.5

170

724

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

24.3

380

2188

A02BA04

ATC

nizatidine; systemic

2.0

24.2

278

1446

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

24.1

301

1612

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

24.1

658

4397

R03CC03

ATC

terbutaline; systemic

3.8

24.1

199

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.6

24.0

715

4876

R60.0

ICD-10 Finland

Localized oedema

1.7

23.8

444

2689

N05CF01

ATC

zopiclone; oral

1.5

23.7

1146

8637

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

23.7

401

2363

7863A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Haemoptysis

9.4

23.5

N05CD07

ATC

temazepam; oral

1.7

23.5

432

2606

R28

ICPC

Limited function/disability (R)

4.8

23.4

109

48099

ICD-8 Finland

Viral pneumonia

9.7

23.2

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

23.0

607

4020

GD1AA, ,

SPAT

1.6

22.9

569

3714

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

22.8

305

1670

R07.3

ICD-10 Finland

Other chest pain

1.8

22.7

380

2230

A01AB04

ATC

amphotericin B; local oral

2.4

22.7

159

680

46401

ICD-8 Finland

Acute laryngitis and tracheitis, Laryngitis acuta (subglottica)

4.8

22.6

108

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

22.6

604

4010

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.6

22.6

136

542

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

19.0

22.5

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

32.4

22.4

N02AC04

ATC

dextropropoxyphene; oral

2.4

22.3

152

642

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

22.1

674

4611

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

22.0

305

1690

R05CB02

ATC

bromhexine; systemic

4.0

21.9

157

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

21.9

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

21.9

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

21.9

569

3753

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.9

21.6

100

348

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

21.4

868

6303

A01AB10

ATC

natamycin; local oral

2.9

21.3

103

367

J01MA01

ATC

ofloxacin; systemic

1.9

21.3

304

1701

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

21.2

396

2397

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

21.1

333

1920

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

21.1

558

3692

4451

FHL

Guitar cutting

2.8

21.1

107

391

C01CA24

ATC

epinephrine; parenteral

2.2

21.0

179

832

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

20.9

437

2726

SPAT1057

SPAT

Peak expiratory flow measurement

4.3

20.9

128

N06AA12

ATC

doxepin; systemic

2.2

20.9

183

861

N05AH04

ATC

quetiapine; oral

1.6

20.8

609

4124

R03BB07

ATC

umeclidinium bromide; inhalant

21.6

20.8

A46

ICD-10 Finland

Erysipelas

1.6

20.8

521

3403

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.5

20.8

778

5556

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

20.7

352

2075

R05DB20

ATC

other cough suppressants - combinations

2.1

20.7

192

924

N06AX16

ATC

venlafaxine; oral

1.7

20.6

455

2878

M48.0

ICD-10 Finland

Spinal stenosis

1.7

20.6

410

2524

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

20.5

267

1449

A06AD11

ATC

lactulose; oral

1.6

20.5

545

3610

R06AE09

ATC

levocetirizine; oral

1.7

20.5

420

2607

R05CB03

ATC

carbocisteine; oral

3.1

20.5

283

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

20.4

447

2824

N06AX11

ATC

mirtazapine; oral

1.4

20.4

1164

8997

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

20.3

322

1858

I50.0

ICD-10 Finland

Congestive heart failure

1.9

20.3

275

1512

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.7

20.3

436

2739

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.7

20.2

386

2349

G44.2

ICD-10 Finland

Tension-type headache

1.7

20.1

436

2747

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

19.9

115

449

GX1E5, ,

SPAT

4.9

19.9

R04

ICPC

Breathing problem other

2.4

19.8

133

558

R03AC18

ATC

indacaterol; inhalant

35.9

19.8

D07AC01

ATC

betamethasone; topical

1.4

19.8

1236

9692

M01AH02

ATC

rofecoxib; oral

1.7

19.7

419

2624

M01AE02

ATC

naproxen; oral, rectal

1.4

19.7

1938

16338

S06.0

ICD-10 Finland

Concussion

1.7

19.7

388

2382

J01DC02

ATC

cefuroxime; systemic

2.1

19.7

184

888

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

19.5

834

6105

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

8.4

19.2

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

19.1

1255

9908

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

19.1

544

3658

T78.4

ICD-10 Finland

Allergy, unspecified

2.3

19.0

142

625

SPAT1216

SPAT

Assessment of functional ability

1.6

19.0

515

3422

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

19.0

107

413

J33.8

ICD-10 Finland

Other polyp of sinus

3.6

19.0

179

J30.3

ICD-10 Finland

Other allergic rhinitis

2.6

18.9

111

437

C03DA01

ATC

spironolactone; oral

1.6

18.9

416

2628

R09

ICPC

Sinus symptom/complaint

1.9

18.8

259

1431

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.0

18.8

281

A01

ICPC

Pain general/multiple sites

1.7

18.8

342

2054

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

2.4

18.8

126

529

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

18.8

185

911

N02AA05

ATC

oxycodone; systemic

1.5

18.7

628

4373

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

27.9

18.7

L03

ICPC

Low back symptom/complaint

1.4

18.6

959

7257

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

18.6

1074

8291

E000001, ,

ATC

1.5

18.6

628

4380

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.4

18.6

129

550

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

18.5

483

3181

J32.4

ICD-10 Finland

Chronic pansinusitis

4.2

18.4

119

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.0

18.2

200

1024

N02BE01

ATC

paracetamol; systemic, rectal

1.5

18.2

3295

30421

A10BA02

ATC

metformin; oral

1.4

18.2

982

7488

R52.2

ICD-10 Finland

Other chronic pain

2.3

18.1

137

606

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

18.1

955

7252

SPAT1262

SPAT

Handing over of treatment supplies

1.5

18.1

571

3925

M25.5

ICD-10 Finland

Pain in joint

1.4

18.1

1081

8389

M04AA01

ATC

allopurinol; systemic

1.6

18.1

465

3052

4640A

ICD-9 Finland

Acute laryngitis and tracheitis, Acute laryngitis

5.7

18.0

B37.0

ICD-10 Finland

Candidal stomatitis

4.5

18.0

J01DA08

ATC

[U] cefaclor

1.8

17.9

305

1797

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

17.9

214

1130

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

17.8

784

5760

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

4.9

17.8

AA1AD

NOMESCO Finland

CT of head and brain

1.4

17.7

984

7535

4919X

ICD-9 Finland

Chronic bronchitis, Unspecified chronic bronchitis

+∞

17.7

49102

ICD-8 Finland

Chronic bronchitis, Purulenta

+∞

17.7

4910A

ICD-9 Finland

Chronic bronchitis, Simple chronic bronchitis

+∞

17.7

L02

ICPC

Back symptom/complaint

1.7

17.7

335

2033

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.2

17.6

218

R03BB06

ATC

glycopyrronium bromide; inhalant

36.9

17.6

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

17.6

723

5241

R05DB05

ATC

pentoxyverine; oral, rectal

2.4

17.6

126

545

H04.10

ICD-10 Finland

Dry eye syndrome

1.6

17.5

381

2400

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

17.5

238

1311

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

17.4

428

2776

N02BF02

ATC

pregabalin; oral

1.9

17.4

225

1218

R49.01

ICD-10 Finland

Functional dysphonia

2.7

17.4

367

SPAT1229

SPAT

Assessment of need for aid

1.8

17.3

259

1469

N06AB03

ATC

fluoxetine; oral

1.6

17.3

378

2382

N02BF01

ATC

gabapentin; oral

1.7

17.3

338

2069

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

17.3

723

5257

K30

ICD-10 Finland

Functional dyspepsia

1.7

17.2

368

2307

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.2

16.9

208

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.9

16.9

127

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

16.8

127

563

N07BA03

ATC

varenicline; oral

2.1

16.8

156

752

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

16.7

314

1903

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.2

16.6

142

662

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

16.6

390

2503

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.8

16.6

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

16.6

862

6517

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

16.5

890

6767

78329

ICD-8 Finland

Symptoms referable to respiratory system, Dyspnoea alia sive NUD

7.3

16.5

A02BX02

ATC

sucralfate; oral

2.2

16.4

141

659

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

16.4

388

2495

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

16.3

230

1280

D02AE01

ATC

carbamide; topical

1.9

16.3

202

1078

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.9

16.3

204

1093

GX1C5, ,

SPAT

12.2

16.3

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

16.3

807

6046

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.6

16.2

351

N06AB06

ATC

sertraline; oral

1.6

16.2

361

2286

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

16.0

1312

10658

M01AH01

ATC

celecoxib; oral

1.5

15.8

572

4036

Z02.7

ICD-10 Finland

Issue of medical certificate

1.8

15.8

260

1517

N05BA12

ATC

alprazolam; oral

1.7

15.8

325

2017

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

15.7

509

3512

E66.8

ICD-10 Finland

Other obesity

2.0

15.7

170

867

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

15.7

957

7423

4911A

ICD-9 Finland

Chronic bronchitis, Mucopurulent chronic bronchitis

+∞

15.6

SPAT1260

SPAT

Consultation of another employee

1.5

15.6

531

3700

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

26.4

15.6

R51.81

ICD-10 Finland

Facial pain NOS

2.6

15.5

336

AN1

Coronary angiography

1.6

15.4

351

2233

S97

ICPC

Chronic ulcer skin

1.8

15.4

213

1180

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

15.4

936

7254

L17

ICPC

Foot/toe symptom/complaint

1.4

15.3

976

7616

T90

ICPC

Diabetes non-insulin dependent

1.4

15.3

794

5988

M02AA07

ATC

piroxicam; topical

1.3

15.3

1179

9477

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

3.7

15.3

127

T82

ICPC

Obesity

2.2

15.2

130

606

B01AA03

ATC

warfarin; systemic

1.4

15.2

665

4865

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

15.1

431

2890

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

15.1

422

2817

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

23.4

15.1

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

5.1

15.0

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.8

14.9

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

14.8

178

941

J01EA01

ATC

trimethoprim; systemic

1.4

14.8

813

6187

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

14.8

169

878

R05DA01

ATC

ethylmorphine; oral

1.8

14.8

244

1424

R06AX12

ATC

terfenadine; oral

2.1

14.8

144

707

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

14.7

232

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

5.3

14.6

Z00.8

ICD-10 Finland

Other general examinations

1.7

14.5

269

1623

E000002, ,

ATC

1.6

14.5

323

2044

N05BB01

ATC

hydroxyzine; systemic

1.9

14.5

194

1063

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

3.1

14.5

202

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

14.4

249

1473

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

14.4

431

2921

S18

ICPC

Laceration/cut

1.3

14.4

1556

13094

M01AB05

ATC

diclofenac; systemic, rectal

1.3

14.4

2318

20563

M54.2

ICD-10 Finland

Cervicalgia

1.7

14.4

271

1643

79388

ICD-8 Finland

Observation, without need for further medical care, Morbi alii definiti

4.9

14.2

C01AA05

ATC

digoxin; systemic

1.7

14.2

300

1872

I45.9

ICD-10 Finland

Conduction disorder, unspecified

4.6

14.2

R79

ICPC

Chronic bronchitis

22.3

14.2

SPAT1249

SPAT

Treatment-related counselling outside office

1.3

14.1

1217

9921

SPAT1310

SPAT

Counselling related to known health issue

1.4

14.0

959

7551

4224

FHL

Endonasal anthrostomy

4.0

14.0

3810A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media

6.7

14.0

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.8

13.9

229

1336

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

13.9

129

622

L01

ICPC

Neck symptom/complaint

1.5

13.9

504

3555

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.8

13.9

196

1093

N03AG01

ATC

valproic acid; systemic, rectal

1.8

13.8

197

1101

M79.1

ICD-10 Finland

Myalgia

1.5

13.8

472

3288

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

3.4

13.8

146

R01AC01

ATC

cromoglicic acid; nasal

2.3

13.8

107

480

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

13.8

1516

12765

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

13.7

755

5744

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

13.7

721

5444

R06.4

ICD-10 Finland

Hyperventilation

3.3

13.7

152

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

13.6

446

3081

XG460

NOMESCO Finland

Short time oxymetry

3.3

13.5

153

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

13.5

2462

22107

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.1

13.4

131

644

40199

ICD-8 Finland

Essential benign hypertension

2.5

13.4

319

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

13.4

792

6092

K59.0

ICD-10 Finland

Constipation

1.8

13.4

189

1054

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

13.3

1320

10952

A28

ICPC

Limited function/disability NOS

1.4

13.2

587

4298

N06AB10

ATC

escitalopram; oral

1.4

13.1

633

4703

N06AX03

ATC

mianserin; oral

2.0

13.0

149

777

R11

ICD-10 Finland

Nausea and vomiting

1.6

12.9

286

1806

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

12.9

482

3415

SPAT1255

SPAT

Intravenous administration of medicine

1.7

12.9

214

1252

S80.0

ICD-10 Finland

Contusion of knee

1.7

12.9

238

1435

N03AX09

ATC

lamotrigine; oral

2.0

12.9

148

772

S01GX02

ATC

levocabastine; ophthalmic

1.9

12.9

160

857

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

2.3

12.8

100

450

C08DA01

ATC

verapamil; systemic

2.0

12.8

133

669

SPAT1325

SPAT

Vaccination

1.3

12.8

987

7898

SPAT1097

SPAT

Recording of ECG

1.5

12.7

437

3048

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

12.7

139

713

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.4

12.6

371

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

12.6

819

6386

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

15.4

12.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

12.6

1359

11381

SPAT1301

SPAT

No procedures

1.3

12.5

961

7681

348

Kela drug reimbursment

Roflumilast

+∞

12.5

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

12.5

300

1933

51900

ICD-8 Finland

Other diseases of respiratory system, Atelectasis pulmonis

24.4

12.4

R03AC19

ATC

olodaterol

20.1

12.4

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

12.4

173

961

D07AA02

ATC

hydrocortisone; topical

1.5

12.4

410

2835

4222

FHL

Endonasal etmoidectomy

5.6

12.4

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

12.4

478

3409

A08

ICPC

Swelling

1.8

12.4

182

1028

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.1

12.4

117

569

XF402

NOMESCO Finland

ECG with work load test

1.6

12.3

314

2054

R05CA10

ATC

expectorants - combinations

2.6

12.3

256

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.2

12.3

433

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.1

12.2

114

551

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.6

12.2

335

2226

K07

ICPC

Swollen ankles/oedema

1.9

12.1

151

809

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

12.1

327

2165

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.7

12.1

247

1529

R06AX26

ATC

fexofenadine; oral

1.8

12.1

185

1058

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

12.1

297

1925

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.9

12.1

145

768

A04

ICPC

Weakness/tiredness general

1.4

12.1

509

3690

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.1

12.0

112

542

R21

ICPC

Throat symptom/complaint

1.4

12.0

608

4553

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

12.0

1822

15892

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.0

12.0

137

714

A03CA02

ATC

clidinium and psycholeptics; oral

1.8

11.9

184

1054

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

11.9

362

J01CA02

ATC

pivampicillin; oral

2.2

11.9

419

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

11.9

500

3622

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

11.8

216

1299

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

3.5

11.8

116

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

3.0

11.8

172

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

11.7

235

1449

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.8

11.7

200

M01AX17

ATC

nimesulide; oral

1.4

11.6

740

5744

SPAT1312

SPAT

General health counselling

1.3

11.6

945

7604

L20.0

ICD-10 Finland

Besnier prurigo

1.7

11.6

195

1146

C09CA01

ATC

losartan; oral

1.3

11.6

825

6512

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

11.6

656

5000

SPAT1211

SPAT

Application of soft bandage

1.6

11.5

255

1611

N06AX05

ATC

trazodone; oral

2.3

11.5

349

D06

ICPC

Abdominal pain localized other

1.6

11.5

270

1730

Z51.6

ICD-10 Finland

Desensitization to allergens

4.2

11.5

WX722

NOMESCO Finland

PEEP

1.9

11.5

140

745

SPAT1240

SPAT

Therapeutic discussion

1.6

11.5

296

1939

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

11.5

380

2628

A02BA03

ATC

famotidine; systemic

2.0

11.5

122

620

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.3

11.4

369

N17

ICPC

Vertigo/dizziness

1.5

11.4

396

2765

N03AE01

ATC

clonazepam; systemic

1.8

11.4

176

1009

R83

ICPC

Respiratory infection other

1.3

11.4

766

5993

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.2

11.4

427

P29

ICPC

Psychological sympt/compl other

1.7

11.4

222

1358

A11

ICPC

Chest pain NOS

1.6

11.4

272

1751

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

11.3

211

1275

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

11.3

664

5086

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

3.3

11.3

129

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

11.3

255

J15.8

ICD-10 Finland

Other bacterial pneumonia

4.1

11.3

D07AC13

ATC

mometasone; topical

1.3

11.3

906

7270

R32

ICD-10 Finland

Unspecified urinary incontinence

2.2

11.3

435

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

11.3

275

1779

S22.3

ICD-10 Finland

Fracture of rib

1.6

11.3

238

1487

UJD02

NOMESCO Finland

Gastroscopy

1.9

11.3

148

808

ZXA10

NOMESCO Finland

Bilateral

1.4

11.3

546

4055

B01AC04

ATC

clopidogrel; oral

1.4

11.2

514

3780

4122

FHL

Tympanostomy (tympanic tube)

3.0

11.2

156

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

2.4

11.2

317

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

11.2

218

1335

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.9

11.1

138

739

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

11.1

575

4318

SPAT1104

SPAT

Monitoring of emergency patient

1.7

11.1

199

1192

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.3

11.0

715

5561

78330

ICD-8 Finland

Symptoms referable to respiratory system, Cough

11.2

11.0

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.8

11.0

170

975

A29

ICPC

General symptom/complaint other

1.5

11.0

418

2970

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.3

11.0

1099

9081

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.9

10.9

133

708

41399

ICD-8 Finland

Angina pectoris, Without mention of hypertensive disease

3.2

10.9

132

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.9

514

3796

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

10.9

100

481

M79.7

ICD-10 Finland

Fibromyalgia

2.3

10.9

377

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

2.5

10.9

284

A12BA01

ATC

potassium chloride; oral

1.8

10.9

151

839

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.1

10.8

143

B37.08

ICD-10 Finland

Other candidal stomatitis

3.9

10.8

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

10.8

2092

18675

B01AB05

ATC

enoxaparin; parenteral

1.3

10.8

958

7789

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.0

10.7

108

538

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.7

551

4129

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

10.7

124

649

Q32.21

ICD-10 Finland

Secondary congenital bronchomalacia

28.1

10.7

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

10.7

193

1157

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

10.7

188

1119

E66.9

ICD-10 Finland

Obesity, unspecified

2.1

10.7

104

512

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

10.7

215

1327

UJF92

NOMESCO Finland

Capsular endoscopy

2.4

10.7

299

G43.9

ICD-10 Finland

Migraine, unspecified

1.8

10.6

160

911

H02AB09

ATC

hydrocortisone; systemic

2.4

10.6

312

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

10.6

172

1001

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

10.6

264

1717

R09.1

ICD-10 Finland

Pleurisy

2.5

10.6

246

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

10.5

221

1378

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

10.5

673

5221

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

10.5

382

2690

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

10.5

401

2851

50300

ICD-8 Finland

Chronic sinusitis, Maxillaris cum empyemate

4.4

10.5

C08DB01

ATC

diltiazem; oral

1.8

10.5

169

982

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

4.8

10.5

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

10.4

136

741

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

10.4

2429

22095

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.5

10.4

300

2015

R03DX07

ATC

roflumilast; oral

+∞

10.4

J43.8

ICD-10 Finland

Other emphysema

+∞

10.4

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

4.1

10.4

R35

ICD-10 Finland

Polyuria

1.6

10.4

218

1361

L12

ICPC

Hand/finger symptom/complaint

1.4

10.3

516

3848

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

4.3

10.3

P03

ICPC

Feeling depressed

1.6

10.3

271

1785

N05CF02

ATC

zolpidem; oral

1.4

10.3

522

3905

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

10.3

324

2219

S29

ICPC

Skin symptom/complaint other

1.4

10.3

625

4812

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

10.2

286

1908

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

10.2

126

674

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

10.2

299

2015

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

10.2

186

1119

N05AA02

ATC

levomepromazine; systemic

1.9

10.2

130

704

UDM02

NOMESCO Finland

Sinoscopy

2.5

10.2

263

C08CA01

ATC

amlodipine; oral

1.3

10.1

1252

10596

M02AA10

ATC

ketoprofen; topical

1.4

10.1

497

3696

C10AA01

ATC

simvastatin; oral

1.3

10.1

1321

11252

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

10.1

186

1122

EB1VA, ,

NOMESCO Finland

1.4

10.1

559

4240

J01MA06

ATC

norfloxacin; oral

1.4

10.1

398

2848

M10.9

ICD-10 Finland

Gout, unspecified

1.6

10.0

223

1411

M05BA04

ATC

alendronic acid; oral

1.6

10.0

256

1674

J98.1

ICD-10 Finland

Pulmonary collapse

5.0

10.0

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

8.4

10.0

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.9

10.0

116

608

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.4

10.0

277

J01AA04

ATC

lymecycline; systemic

1.4

10.0

381

2708

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

10.0

833

6707

48499

ICD-8 Finland

Acute interstitial pneumonia

14.6

10.0

5901A

ICD-9 Finland

Infections of kidney, Acute pyelonephritis

3.2

10.0

119

R01AD59

ATC

mometasone, combinations; nasal

1.7

10.0

192

1172

E000006, ,

ATC

1.7

9.9

184

1112

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

9.9

214

1346

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.1

9.9

426

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

9.8

180

1084

A02BC04

ATC

rabeprazole; oral

1.6

9.8

258

1698

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

9.8

141

792

M01AH05

ATC

etoricoxib; oral

1.2

9.8

2081

18677

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

9.8

371

2633

N30.0

ICD-10 Finland

Acute cystitis

1.4

9.8

501

3750

WX892

NOMESCO Finland

Monitored bed care

1.6

9.8

224

1428

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

4.4

9.8

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

4.9

9.8

A99

ICPC

Disease/condition unspecnature/site

1.5

9.8

320

2208

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.8

662

5176

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

9.8

120

642

SPAT1234

SPAT

Support of social functional capacity

1.7

9.8

173

1033

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

9.7

288

1946

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

9.7

287

SPAT1360

SPAT

Extensive global examination

1.6

9.7

196

1211

A10AB05

ATC

insulin aspart; parenteral

1.6

9.7

247

1614

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

9.7

306

207

Kela drug reimbursment

Chronic arrhythmias

1.4

9.7

484

3610

XF600

NOMESCO Finland

Bloodpressure measurement

1.7

9.6

186

1136

J01GB01

ATC

tobramycin; inhalant, parenteral

55.1

9.6

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

9.6

505

3797

ACC51

NOMESCO Finland

Release of median nerve

1.6

9.6

220

1404

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

2.9

9.6

154

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

9.6

919

7532

Z3231

NOMESCO Finland

Registered nurse

1.3

9.6

808

6513

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

9.5

177

1070

SPAT1252

SPAT

Overall medication plan or its review

1.6

9.5

201

1258

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.1

9.5

420

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.3

9.5

297

R99

ICPC

Respiratory disease other

2.4

9.4

248

R03

ICPC

Wheezing

3.3

9.4

103

4111X

ICD-9 Finland

Other acute and subacute forms of ischaemic heart disease, Intermediate coronary syndrome[PITKITTYNYT ANGINA PECTORIS -KOHTAUS,MÄÄRITTELEMÄT]

3.0

9.4

134

N07BB01

ATC

disulfiram; oral

1.8

9.4

138

781

R03BB05

ATC

aclidinium bromide; inhalant

30.1

9.4

M01AB51

ATC

indometacin, combinations; oral, rectal

2.2

9.4

336

R03DX09

ATC

mepolizumab; parenteral

+∞

9.4

3028

Kela drug reimbursment

Mepolizumab

+∞

9.4

297, ,

Kela drug reimbursment

+∞

9.4

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

9.4

685

5412

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

9.3

268

1799

J96.0

ICD-10 Finland

Acute respiratory failure

3.1

9.3

124

A06AC51

ATC

ispaghula, combinations; oral

1.8

9.3

141

805

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.9

9.3

107

560

N03AF02

ATC

oxcarbazepine; oral

2.0

9.2

506

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

9.2

376

2706

Y0399

ICD-8 Finland

Investigation of circulatory system

2.9

9.2

141

Z71.8

ICD-10 Finland

Other specified counselling

1.3

9.2

1043

8719

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

9.2

326

2286

7806A

ICD-9 Finland

General symptoms, Pyrexia of unknown origin

3.5

9.2

A07DA03

ATC

loperamide; oral

1.9

9.2

103

535

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.7

9.2

169

Y96.9

ICD-10 Finland

Unspecified type of accident

2.4

9.2

270

R00.2

ICD-10 Finland

Palpitations

1.6

9.1

230

1500

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

9.1

140

803

Y1202

ICD-8 Finland

Skin tests, Allergy tests

7.7

9.1

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.4

9.1

246

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

9.1

265

1785

A10AE04

ATC

insulin glargine; parenteral

1.5

9.1

308

2140

N07CA01

ATC

betahistine; oral

1.6

9.1

223

1446

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

4.6

9.0

IHZ05, ,

SPAT

1.9

9.0

115

623

L15

ICPC

Knee symptom/complaint

1.3

8.8

749

6035

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

8.8

118

650

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.7

8.8

158

948

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

8.8

439

3274

Z50.1

ICD-10 Finland

Other physical therapy

1.7

8.7

156

934

F34.1

ICD-10 Finland

Dysthymia

1.9

8.7

516

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

8.7

213

1380

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

8.7

244

1630

N03AF01

ATC

carbamazepine; oral, rectal

1.7

8.7

154

920

M84.0

ICD-10 Finland

Malunion of fracture

4.1

8.7

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.5

8.7

215

Q32.0

ICD-10 Finland

Congenital tracheomalacia

50.1

8.7

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

8.6

349

2508

A03DA02

ATC

pitofenone and analgesics; systemic

2.3

8.6

284

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

8.6

167

1023

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.7

8.6

158

S76

ICPC

Skin infection other

1.7

8.6

159

962

K08.80

ICD-10 Finland

Toothache NOS

1.5

8.6

260

1767

C08CA02

ATC

felodipine; oral

1.5

8.6

288

1999

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

8.6

121

678

R55

ICD-10 Finland

Syncope and collapse

1.4

8.5

346

2487

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

8.5

126

715

F61.0

ICD-10 Finland

Mixed personality disorders

2.5

8.5

199

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.1

8.5

115

R4110, ,

SPAT

1.4

8.5

382

2795

C07AB02

ATC

metoprolol; systemic

1.3

8.5

643

5100

59010

ICD-8 Finland

Infections of kidney, Pyelonephritis

2.6

8.5

188

J32

ICD-10 Finland

Chronic sinusitis

3.4

8.5

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

8.5

399

2945

50708

ICD-8 Finland

Hay fever, Alia definita

6.4

8.5

5191A

ICD-9 Finland

Other diseases of respiratory system, Other diseases of trachea and bronchus, not elsewhere classified

20.1

8.5

4742A

ICD-9 Finland

Chronic disease of tonsils and adenoids, Adenoid vegetations

2.5

8.5

212

Z00.0

ICD-10 Finland

General medical examination

1.3

8.4

579

4530

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

8.4

159

967

N05AF03

ATC

chlorprothixene; systemic

2.1

8.4

352

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.1

8.4

372

L29

ICPC

Musculoskeletal sympt/complt other

1.5

8.4

260

1775

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.9

8.4

127

K03.66

ICD-10 Finland

Tooth plaque

1.5

8.4

224

1482

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

8.4

122

690

K02.1

ICD-10 Finland

Caries of dentine

1.2

8.4

1934

17395

UDC00

NOMESCO Finland

Ear microscopy

1.6

8.4

205

1330

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

3.5

8.4

4239

FHL

Other measure in this category

4.9

8.4

ZXA05

NOMESCO Finland

Left side

1.3

8.3

729

5895

XQ802

NOMESCO Finland

Epicutan test

1.9

8.3

104

561

XA402

NOMESCO Finland

ENMG

2.1

8.3

354

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

8.3

422

M35.7

ICD-10 Finland

Hypermobility syndrome

2.9

8.2

123

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

8.2

128

739

H66.9

ICD-10 Finland

Otitis media, unspecified

1.6

8.2

173

1083

N06AB05

ATC

paroxetine; oral

1.6

8.2

164

1013

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.3

8.2

689

5542

DHB20

NOMESCO Finland

Polypectomy of internal nose

2.9

8.2

129

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

8.1

594

4686

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

8.1

122

696

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

8.1

508

R52.0

ICD-10 Finland

Acute pain

1.9

8.1

100

537

K10.3

ICD-10 Finland

Alveolitis of jaws

1.7

8.1

140

832

A10AC01

ATC

insulin (human); parenteral

1.5

8.1

251

1714

A10BH01

ATC

sitagliptin; oral

1.5

8.1

279

1946

M05BA07

ATC

risedronic acid; oral

2.0

8.0

454

I20.00

ICD-10 Finland

Unstable angina

1.9

8.0

489

KMAK, ,

NOMESCO Finland

1.2

8.0

1631

14466

D80.1

ICD-10 Finland

Nonfamilial hypogammaglobulinaemia

10.0

8.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.4

8.0

364

2670

212

Kela drug reimbursment

Gout

2.1

8.0

326

X58

ICD-10 Finland

Exposure to other specified factors

1.4

8.0

462

3524

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

8.0

300

2128

P99

ICPC

Psychological disorders other

2.0

7.9

456

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.6

7.9

194

1259

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.0

7.9

115

00920

ICD-8 Finland

Diarrhoeal disease, Gastroenteritis (acuta) (infectiosa)

1.8

7.9

106

585

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.3

7.9

263

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.6

7.9

179

1141

6453

FHL

Radical surgery of hemorrhoids

2.2

7.9

302

J34.2

ICD-10 Finland

Deviated nasal septum

1.6

7.9

165

1032

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

7.8

141

847

G04BD04

ATC

oxybutynin; oral, transdermal

1.6

7.8

165

1033

D01

ICPC

Abdominal pain/cramps general

1.4

7.8

345

2519

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.8

7.8

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

3.2

7.8

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

1.8

7.8

102

559

J05AB11

ATC

valaciclovir; oral

1.4

7.8

417

3143

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.7

7.8

131

774

R51

ICD-10 Finland

Headache

1.6

7.7

154

950

A10BK01

ATC

dapagliflozin; oral

1.5

7.7

231

1565

W19

ICD-10 Finland

Unspecified fall

1.4

7.7

307

2199

N06AA04

ATC

clomipramine; systemic

2.4

7.7

209

WW200

NOMESCO Finland

Immunization

2.0

7.7

405

SPAT1153

SPAT

Removal of sutures

1.2

7.7

929

7796

S20

ICPC

Corn/callosity

2.1

7.7

311

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

7.7

260

1806

49000, ,

ICD-8 Finland

45.1

7.7

M05BA01

ATC

etidronic acid; systemic

3.9

7.7

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

7.7

214

1430

L13

ICPC

Hip symptom/complaint

1.3

7.7

546

4292

L04AA06

ATC

mycophenolic acid; systemic

2.2

7.7

260

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.2

7.6

273

38110

ICD-8 Finland

Otitis media without mention of mastoiditis, Chronic

3.3

7.6

S60.9

ICD-10 Finland

Superficial injury of wrist and hand, unspecified

4.5

7.6

M47.82

ICD-10 Finland

Other spondylosis, cervical region

1.8

7.6

116

665

N05AB01

ATC

dixyrazine; systemic

2.8

7.6

134

WX002

NOMESCO Finland

Sedation and analgesia

1.3

7.6

543

4270

SPAT1284

SPAT

Extensive health certificate

2.0

7.6

381

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

7.5

315

2277

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.5

478

3695

L16

ICPC

Ankle symptom/complaint

1.4

7.5

331

2414

48199

ICD-8 Finland

Pneumococcal pneumonia

8.9

7.5

30180

ICD-8 Finland

Personality disorders, Immatura

4.1

7.5

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.0

7.5

423

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

7.5

384

2872

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

7.5

132

789

J20.8

ICD-10 Finland

Acute bronchitis due to other specified organisms

7.1

7.5

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.7

7.5

147

L14

ICPC

Leg/thigh symptom/complaint

1.5

7.5

237

1627

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.3

7.5

475

3675

78880

ICD-8 Finland

Other general symptoms, Pyrexia of unknown origin

3.7

7.4

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

7.4

301

2164

1410

FHL

Laparoscopy

2.2

7.4

283

J01XB01

ATC

colistin; inhalant, parenteral

80.2

7.4

K08.3

ICD-10 Finland

Retained dental root

1.5

7.4

240

1654

R09.3

ICD-10 Finland

Abnormal sputum

2.8

7.4

125

R12

ICD-10 Finland

Heartburn

1.5

7.4

243

1679

A01AC01

ATC

triamcinolone; local oral

2.3

7.4

232

M01AX01

ATC

nabumetone; oral

1.8

7.4

115

664

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.5

7.4

189

A10BG03

ATC

pioglitazone; oral

2.0

7.4

384

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.8

7.4

107

605

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.8

7.4

114

657

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.7

7.4

143

877

F41.8

ICD-10 Finland

Other specified anxiety disorders

1.9

7.4

454

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

7.4

144

885

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

7.4

1119

9621

R06.5

ICD-10 Finland

Mouth breathing

1.4

7.4

266

1873

R5110, ,

SPAT

1.5

7.4

245

1698

-1, ,

NOMESCO Finland

1.2

7.3

976

8274

J05AH02

ATC

oseltamivir; oral

4.0

7.3

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

3.0

7.3

104

L29.9

ICD-10 Finland

Pruritus, unspecified

2.0

7.3

413

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.0

7.3

413

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

7.3

196

1298

S01

ICPC

Pain/tenderness of skin

1.7

7.3

128

764

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

7.3

189

1242

R053, ,

ICD-10 Finland

1.8

7.3

101

563

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

7.3

124

734

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

7.3

285

E66.0

ICD-10 Finland

Obesity due to excess calories

3.0

7.3

N05BA02

ATC

chlordiazepoxide; systemic

2.0

7.3

345

R33

ICD-10 Finland

Retention of urine

1.5

7.3

244

1693

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.5

7.3

211

1422

46209

ICD-8 Finland

Acute pharyngitis, Unspecified

2.9

7.3

110

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

7.3

155

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

7.2

145

897

SPAT1283

SPAT

Restricted health certificate

1.3

7.2

437

3354

L04AD02

ATC

tacrolimus; systemic

2.7

7.2

138

D11AH01

ATC

tacrolimus; topical

3.3

7.2

R03DB04

ATC

theophylline and adrenergics; systemic

15.8

7.2

G04CA02

ATC

tamsulosin; oral

1.3

7.2

767

6341

C10AC01

ATC

colestyramine; oral

2.0

7.2

374

N71.9

ICD-10 Finland

Inflammatory disease of uterus, unspecified

4.3

7.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.2

2283

21026

R49.08

ICD-10 Finland

Other specified dysphonia

2.2

7.2

261

H65.2

ICD-10 Finland

Chronic serous otitis media

2.6

7.2

156

XG499

NOMESCO Finland

Other fysiological examination of respiatory function

4.5

7.2

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

7.2

1003

8547

P06

ICPC

Sleep disturbance

1.4

7.2

365

2729

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.0

7.2

368

A10BJ06

ATC

semaglutide; parenteral

1.6

7.2

153

962

H01

ICPC

Ear pain/earache

1.4

7.2

305

2213

J94.9

ICD-10 Finland

Pleural condition, unspecified

3.9

7.2

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

7.1

251

1758

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

7.1

178

1161

B44.1

ICD-10 Finland

Other pulmonary aspergillosis

20.0

7.1

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.6

7.1

145

I20.09

ICD-10 Finland

Unstable angina

1.6

7.1

171

1106

A92

ICPC

Allergy/allergic reaction NOS

2.0

7.1

376

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

7.1

336

2482

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

2.3

7.1

224

L08

ICPC

Shoulder symptom/complaint

1.3

7.1

688

5626

U71

ICPC

Cystitis/urinary infection other

1.6

7.1

178

1163

TAB00

NOMESCO Finland

Lumbar puncture

1.7

7.1

126

756

C08CA07

ATC

nisoldipine; oral

2.4

7.1

187

J01X

ATC

OTHER ANTIBACTERIALS

4.1

7.1

J92.9

ICD-10 Finland

Pleural plaque without asbestos

3.0

7.1

101

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.0

7.1

101

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

7.1

156

989

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

7.1

370

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

7.1

360

2692

R07.1

ICD-10 Finland

Chest pain on breathing

2.3

7.1

212

P01

ICPC

Feeling anxious/nervous/tense

1.4

7.0

319

2339

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.5

7.0

186

1229

U02

ICPC

Urinary frequency/urgency

1.3

7.0

403

3069

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

7.0

125

750

3812A

ICD-9 Finland

Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media

2.6

7.0

146

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

7.0

238

1656

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.5

7.0

179

1174

3004A

ICD-9 Finland

Neurotic disorders, Neurotic depression

4.2

7.0

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.0

1758

15840

EBA00

NOMESCO Finland

Extraction of tooth

1.2

7.0

1116

9636

L30.3

ICD-10 Finland

Infective dermatitis

1.8

7.0

528

N06AA10

ATC

nortriptyline; systemic

2.2

7.0

258

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

7.0

166

1072

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.4

7.0

EC1VA, ,

NOMESCO Finland

1.6

6.9

136

837

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.3

6.9

586

4709

N04BC05

ATC

pramipexole; oral

1.5

6.9

213

1453

SPAT1167

SPAT

Insertion of urinary catheter

1.8

6.9

536

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

6.9

231

1602

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.6

6.9

138

853

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

6.9

176

1153

E883A

ICD-9 Finland

Fall into hole or other opening in surface

1.6

6.9

157

1002

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.4

6.9

177

H25.8

ICD-10 Finland

Other senile cataract

1.4

6.9

342

2547

NHQ40

NOMESCO Finland

Amputation of toe

2.2

6.9

240

QDB10, ,

SPAT

2.0

6.9

381

J96.9

ICD-10 Finland

Respiratory failure, unspecified

3.6

6.9

30320

ICD-8 Finland

Alcoholism, Alcoholic addiction

3.6

6.9

Z01.2

ICD-10 Finland

Dental examination

1.2

6.9

1427

12632

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

6.8

553

I50

ICD-10 Finland

Heart failure

1.8

6.8

502

RS221, ,

NOMESCO Finland

2.5

6.8

166

J02AC02

ATC

itraconazole; systemic

1.3

6.8

497

3917

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.0

6.8

375

R10.0

ICD-10 Finland

Acute abdomen

1.8

6.8

532

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

6.8

181

1198

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

6.8

430

3322

R06AX11

ATC

astemizole; oral

1.9

6.8

389

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.5

6.8

180

1190

M80.4

ICD-10 Finland

Drug-induced osteoporosis with pathological fracture

4.1

6.8

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

6.8

341

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.3

6.8

517

4099

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.4

6.8

265

1894

Z29

ICPC

Social problem NOS

2.0

6.8

348

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

9.3

6.8

S81.0

ICD-10 Finland

Open wound of knee

2.3

6.8

216

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

6.8

266

1904

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

6.7

124

751

I80.9

ICD-10 Finland

Phlebitis and thrombophlebitis of unspecified site

2.5

6.7

167

62200

ICD-8 Finland

Infective diseases of uterus (except cervix), vagina and vulva, Endometritis acuta

3.6

6.7

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

2.0

6.7

349

P28

ICPC

Limited function/disability (P)

2.9

6.7

104

X01

ICPC

Genital pain female

3.1

6.7

Z2446

NOMESCO Finland

Social worker

1.5

6.7

173

1137

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

6.7

172

1129

R01

ICPC

Pain respiratory system

2.3

6.7

198

R04.0

ICD-10 Finland

Epistaxis

1.5

6.7

226

1571

K29.7

ICD-10 Finland

Gastritis, unspecified

1.8

6.7

100

572

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.2

6.7

813

6819

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.5

6.7

233

1631

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

2.4

6.7

174

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

22.5

6.7

5198X

ICD-9 Finland

Other diseases of respiratory system, not elsewhere classified

22.5

6.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.1

6.6

303

E87.6

ICD-10 Finland

Hypokalaemia

1.8

6.6

100

573

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.3

6.6

199

K77

ICPC

Heart failure

2.0

6.6

344

OAB50, ,

SPAT

1.4

6.6

238

1675

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

6.6

193

IGY02, ,

SPAT

2.3

6.6

193

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.3

6.6

193

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

6.4

6.6

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.4

6.6

187

79399

ICD-8 Finland

Observation, without need for further medical care, Unspecified

2.6

6.6

139

SGA01

NOMESCO Finland

Emergency treatment

1.3

6.6

482

3800

P76

ICPC

Depressive disorder

1.5

6.6

173

1142

A10BJ02

ATC

liraglutide; parenteral

1.9

6.6

429

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

2.0

6.6

311

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

2.9

6.6

100

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.3

6.6

219

O28.8

ICD-10 Finland

Other abnormal findings on antenatal screening of mother

3.2

6.6

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

3.2

6.6

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.7

6.5

119

719

M54.8

ICD-10 Finland

Other dorsalgia

1.7

6.5

126

773

D12

ICPC

Constipation

1.7

6.5

108

636

KH1AD

NOMESCO Finland

CT of urinary organs

1.7

6.5

104

606

H57.1

ICD-10 Finland

Ocular pain

1.7

6.5

106

621

N30.2

ICD-10 Finland

Other chronic cystitis

2.7

6.5

117

R24

ICPC

Haemoptysis

3.8

6.5

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

6.5

170

1121

-69

ICPC

Other reason for encounter NEC

1.7

6.5

101

584

DJD20

NOMESCO Finland

Plastic repair of septum of nose

1.7

6.5

109

644

P17

ICPC

Tobacco abuse

2.5

6.5

146

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

6.5

2168

19970

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

1.8

6.5

525

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

2.5

6.5

158

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

2.5

6.5

158

WW200, ,

SPAT

1.2

6.5

885

7510

R49.03

ICD-10 Finland

Atrophic dysphonia

2.6

6.4

135

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.4

6.4

177

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

2.1

6.4

280

R01BA01

ATC

phenylpropanolamine; oral

1.6

6.4

138

870

J04.0

ICD-10 Finland

Acute laryngitis

1.8

6.4

476

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

2.9

6.4

D06AX01

ATC

fusidic acid; topical

1.4

6.4

267

1931

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.7

6.4

572

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

2.8

6.4

107

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

3.3

6.4

SFA20

NOMESCO Finland

Two-surface restoration

1.2

6.4

1891

17232

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.4

484

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.5

6.4

170

1126

N01

ICPC

Headache

1.4

6.4

282

2060

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.9

6.4

441

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

6.4

232

1638

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

1.9

6.3

385

R07

ICPC

Sneezing/nasal congestion

1.5

6.3

164

1080

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

3.0

6.3

M54.3

ICD-10 Finland

Sciatica

1.5

6.3

161

1056

J01CA08

ATC

pivmecillinam; oral

1.2

6.3

1120

9750

D11

ICPC

Diarrhoea

1.4

6.3

339

2556

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.3

117

711

M54

ICD-10 Finland

Dorsalgia

1.3

6.3

357

2714

1450

FHL

Otomicroscopy

5.2

6.3

L04AA13

ATC

[U] leflunomide

2.0

6.3

330

K04.0

ICD-10 Finland

Pulpitis

1.4

6.3

258

1861

38199

ICD-8 Finland

Otitis media without mention of mastoiditis, Unspecified

5.5

6.3

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

1.8

6.3

553

41291

ICD-8 Finland

Chronic ischaemic heart disease, Status post infarctum cordis, hypertonia non indicata

3.5

6.3

C09CA06

ATC

candesartan; oral

1.2

6.3

719

5988

UJF02

NOMESCO Finland

Peroral enteroscopy

3.3

6.3

5150X

ICD-9 Finland

Postinflammatory pulmonary fibrosis[FIBROSIS PULMONUM E CAUSA IGNOTA]

18.0

6.3

ZX120, ,

SPAT

2.3

6.3

192

RD210, ,

NOMESCO Finland

2.3

6.3

192

GDC00

NOMESCO Finland

Lobectomy of lung

3.8

6.3

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

6.3

324

2430

J43.2

ICD-10 Finland

Centrilobular emphysema

+∞

6.2

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

2.7

6.2

120

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

6.2

1176

10297

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.3

6.2

205

Z3226

NOMESCO Finland

Physiotherapist

1.3

6.2

495

3947

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.4

6.2

168

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.5

6.2

144

WZC30

NOMESCO Finland

Teaching

1.3

6.2

460

3636

ZXD05

NOMESCO Finland

Urgent procedure

1.2

6.2

923

7903

J01DC04

ATC

cefaclor; oral

2.7

6.2

115

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.7

6.2

113

685

S80.9

ICD-10 Finland

Superficial injury of lower leg, unspecified

4.0

6.2

A10BH02

ATC

vildagliptin; oral

2.0

6.2

285

4140X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Coronary atherosclerosis[ATHEROSCLEROSIS ARTER CORON CORDIS,MÄÄRITTELEMÄT]

3.1

6.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.0

6.1

292

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

6.1

140

896

SPAT1060

SPAT

Administration of oxygen

5.7

6.1

U07

ICPC

Urine symptom/complaint other

1.4

6.1

234

1667

J15

ICD-10 Finland

Bacterial pneumonia, not elsewhere classified

7.7

6.1

L30.4

ICD-10 Finland

Erythema intertrigo

2.2

6.1

207

C07AA05

ATC

propranolol; systemic

1.3

6.1

565

4591

SPAT1081

SPAT

Cardiorespiratory global assessment

1.6

6.1

138

882

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

6.1

106

634

7931A

ICD-9 Finland

Nonspecific abnormal findings on radiological and other examination of body structure, Lung field

4.1

6.1

GD1UN

NOMESCO Finland

Lung circulation SPECT

3.8

6.1

SPAT1247

SPAT

Outpatient detoxication and monitoring

3.8

6.1

1243

FHL

Bronchoscopy and other therapeutic procedure

12.5

6.1

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.9

6.1

398

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.9

6.0

342

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

1.9

6.0

349

A08AA02

ATC

fenfluramine; oral

2.9

6.0

6918B

ICD-9 Finland

Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]

3.1

6.0

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1.8

6.0

508

S11

ICPC

Skin infection post-traumatic

2.4

6.0

164

30399

ICD-8 Finland

Other and unspecified alcoholism

6.7

6.0

N06AX12

ATC

bupropion; oral

1.5

6.0

189

1297

DHB50

NOMESCO Finland

Turbinoplasty

1.9

6.0

385

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.0

6.0

322

A10BK03

ATC

empagliflozin; oral

1.4

6.0

290

2151

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

458

1379

3.62

127.38

1.6

1.1

308.51

206.84

u/ml

1.34

437

1263

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

485

1582

3.35

118.73

1.6

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

106

13.09

110.34

1.4

1.1

2.59

0.87

u/ml

0.96

(3023419) Bacteria identified in Sputum by Culture

144

190

7.82

102.88

4.2

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

268

848

3.31

67.92

3.4

2.3

—

(3013115) Eosinophils [#/volume] in Blood

2209

16463

1.76

64.86

8.1

6.5

0.21

0.19

e9/l

7.95

1975

14251

(3022096) Basophils/Leukocytes in Blood

2006

14716

1.72

60.76

8.6

6.6

0.66

0.67

0.85

1893

13753

(3006504) Eosinophils/Leukocytes in Blood

2005

14720

1.72

60.44

8.4

6.5

2.95

2.79

2.05

1891

13771

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

898

5194

1.94

60.37

2.5

1.8

—

(3019069) Monocytes/Leukocytes in Blood

2007

14752

1.72

60.13

8.6

6.6

8.87

8.96

0.73

1897

13812

(3023368) Bacteria identified in Blood by Culture

1344

8947

1.75

56.64

5.6

4.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

435

1949

2.38

56.53

4.6

3.2

5.22

5.09

kpa

2.14

415

1850

(3002030) Lymphocytes/Leukocytes in Blood

2031

15164

1.69

55.83

8.5

6.5

27.08

27.84

2.39

1936

14354

(3018010) Neutrophils/Leukocytes in Blood

1995

14854

1.68

55.19

8.3

6.4

57.75

57.26

1.09

1908

14166

(3006315) Basophils [#/volume] in Blood

2120

16042

1.68

55.09

7.9

6.3

0.04

e9/l

1.85

1882

13696

(3019198) Lymphocytes [#/volume] in Blood

2152

16419

1.67

53.56

8.1

6.3

1.90

1.92

e9/l

0.18

1944

14360

(3001604) Monocytes [#/volume] in Blood

2108

16004

1.67

53.43

7.9

6.3

0.62

0.58

e9/l

11.45

1872

13665

(3009343) pH of Capillary blood

419

1897

2.35

53.04

4.5

3.2

7.41

7.42

0.27

367

1533

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1070

6806

1.78

51.97

2.0

1.8

1.12

1.30

mg/l

1.14

843

5239

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1374

9400

1.70

51.30

3.8

3.1

1484.39

1491.17

ng/l

0.02

1193

8006

(4015189) Microbial culture of sputum

13.57

50.21

3.4

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

369

1639

2.38

48.65

4.4

3.1

1.82

1.64

mmol/l

0.41

283

1166

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

200

4.84

42.30

3.8

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1420

10235

1.60

40.86

3.2

2.6

54.46

68.44

u/l

1.09

1306

9477

(3032080) INR in Blood by Coagulation assay

1944

15078

1.56

40.54

17.4

15.5

1.26

1.28

inr

1.03

1677

12573

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1651

12386

1.56

39.62

5.1

3.6

85.53

99.93

ng/l

0.10

1184

8644

(3022313) Gas panel - Capillary blood

307

1376

2.33

39.45

4.5

3.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2254

18154

1.55

39.07

11.0

9.7

4.39

4.08

e9/l

7.58

2004

15637

(3007853) Bacteria identified in Skin by Aerobe culture

624

3717

1.80

36.34

2.1

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

634

3815

1.79

35.63

2.4

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2110

16977

1.51

35.08

7.3

6.6

10.57

12.22

umol/l

11.05

2008

16172

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

276

1251

2.29

34.48

2.5

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2013

16091

1.50

34.18

8.9

7.3

1.21

mmol/l

0.02

1762

13869

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2757

23551

1.54

33.93

5.5

4.1

13.33

11.58

mm/h

7.25

2597

22031

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

100

261

3.90

33.81

1.1

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1364

10117

1.53

32.76

2.5

2.2

195.15

231.75

u/l

0.75

1289

9589

(3013826) Glucose [Moles/volume] in Serum or Plasma

2318

19235

1.48

31.62

6.5

4.9

6.82

6.75

mmol/l

0.87

2241

18199

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

241

1070

2.33

31.56

4.8

3.3

25.01

24.77

mmol/l

0.68

222

972

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

252

1151

2.27

30.88

2.2

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

141

493

2.93

30.03

1.2

1.1

1.82

2.52

u/ml

0.38

229

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

916

6351

1.57

29.24

5.3

3.7

464.99

613.30

ng/l

0.23

710

4970

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

590

2.73

29.23

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

198

843

2.42

28.49

1.4

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

127

435

2.98

28.07

1.1

4.39

4.83

u/ml

0.14

215

(3005719) IgG [Mass/volume] in Serum or Plasma

422

2418

1.83

27.50

3.3

2.8

10.15

10.75

g/l

2.31

396

2222

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

5.82

27.08

4.9

3.1

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

404

2295

1.84

27.05

1.9

1.7

—

(3042936) Bacteria identified in Isolate by Culture

691

4565

1.62

26.78

2.4

2.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

355

1945

1.90

26.60

2.0

1.6

—

(3042631) Mycobacterium sp identified in Specimen

298

3.35

26.45

3.6

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

568

3587

1.68

26.25

2.5

1.7

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1777

14331

1.43

26.09

7.9

6.7

1.21

mmol/l

0.18

1641

13244

(3009445) Proteinase 3 Ab [Units/volume] in Serum

255

1255

2.10

25.88

1.6

24.11

16.84

iu/ml

—

(3017732) Neutrophils [#/volume] in Blood

611

3968

1.64

25.26

3.6

3.1

4.41

4.71

e9/l

0.69

513

3431

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

165

684

2.47

25.17

2.0

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

115

398

2.94

24.98

1.1

1.0

1.52

1.25

u/ml

0.24

167

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

416

2447

1.78

24.75

3.9

2.9

193.78

209.86

ng/l

0.31

370

2222

(3008401) Mugwort IgE Ab [Units/volume] in Serum

120

428

2.86

24.69

1.1

1.0

1.04

1.25

u/ml

0.15

157

(3000494) Fungus identified in Specimen by Culture

581

3769

1.63

24.04

1.8

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

186

836

2.28

23.66

1.6

1.3

13.24

8.99

iu/ml

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

224

1086

2.12

23.63

1.5

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

129

490

2.69

23.56

1.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

743

2.36

23.53

1.2

1.1

5.63

3.70

0.81

122

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

134

4.38

23.14

2.3

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

134

4.38

23.14

2.3

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

134

4.38

23.14

2.3

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

134

4.38

23.14

2.3

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

165

711

2.38

23.14

2.1

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1401

11035

1.41

22.49

3.8

3.3

29.92

35.53

u/l

3.08

1324

10400

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1767

14493

1.39

22.31

2.8

2.4

76.38

77.05

nmol/l

0.43

1596

13126

(3019225) pH of Specimen

478

3029

1.66

21.57

5.1

4.3

7.37

7.35

1.24

353

2178

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

5.51

21.46

1.1

10.70

9.87

u/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2415

20927

1.38

21.44

6.3

4.6

1876.19

1965.37

e6/l

0.03

290

(3024139) IgG subclass 3 [Mass/volume] in Serum

271

3.18

21.31

1.6

1.3

0.42

0.43

g/l

0.05

194

(3028192) IgG subclass 2 [Mass/volume] in Serum

271

3.18

21.31

1.6

1.3

2.78

2.97

g/l

0.56

193

(3027135) IgG subclass 1 [Mass/volume] in Serum

272

3.17

21.18

1.6

1.3

6.42

6.97

g/l

0.93

195

(3000850) Epithelial cells [#/volume] in Urine

984

7336

1.45

21.13

3.5

2.7

5.22

5.23

e6/l

0.01

904

6683

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

109

403

2.75

21.01

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

329

1896

1.80

20.89

2.0

1.9

1.23

1.35

g/l

0.58

303

1745

(3026493) Urate [Moles/volume] in Serum or Plasma

1133

8697

1.42

20.67

3.1

2.7

352.65

347.46

umol/l

0.90

1006

7700

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

126

509

2.52

20.35

1.5

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1108

8491

1.42

20.34

2.8

2.3

3.01

2.76

mg/l

2.18

953

7302

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

768

5500

1.49

20.14

1.4

1.3

28.42

30.88

iu/ml

0.27

242

1651

(3004789) Transferrin [Mass/volume] in Serum or Plasma

734

5212

1.50

20.07

3.2

2.6

2.35

2.30

g/l

1.67

667

4813

(3014133) Dog dander IgE Ab [Units/volume] in Serum

357

2.82

20.01

1.1

1.0

6.29

1.51

u/ml

2.07

158

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

684

4802

1.51

19.72

3.3

2.7

21.83

23.34

2.03

625

4460

(3022948) Iron [Moles/volume] in Serum or Plasma

772

5581

1.47

19.22

3.2

2.6

12.64

13.37

umol/l

1.89

708

5195

(3003396) Base excess in Arterial blood by calculation

536

3594

1.57

19.02

7.7

8.2

1.14

0.63

mmol/l

2.28

443

2917

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2787

24938

1.38

18.98

10.1

8.0

77.70

79.34

u/l

1.27

2669

23654

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

223

3.27

18.96

2.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

223

3.27

18.96

2.2

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

223

3.27

18.96

2.2

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

715

5111

1.48

18.80

1.4

1.3

19.70

11.96

u/ml

0.58

262

2012

(3019977) pH of Arterial blood

537

3612

1.56

18.79

7.8

8.3

7.42

7.41

0.28

324

1938

(3023430) Cat dander IgE Ab [Units/volume] in Serum

338

2.79

18.55

1.1

1.0

6.07

2.61

u/ml

1.01

128

(3025018) Bordetella pertussis Ab [Titer] in Serum

177

3.54

18.54

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

845

6259

1.44

18.43

1.6

1.5

2.44

2.46

g/l

0.08

565

3958

(4062490) Immunoglobulin typing, IgG

270

3.00

18.25

1.6

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

617

4316

1.51

17.97

1.4

1.3

443.71

500.62

titre

0.42

140

904

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

295

2.89

17.86

2.5

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

532

3614

1.54

17.75

7.9

8.3

11.19

12.86

kpa

13.49

505

3469

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

532

3616

1.54

17.70

7.9

8.3

5.17

5.03

kpa

2.17

506

3474

(3021960) Folate [Moles/volume] in Serum or Plasma

1162

9151

1.38

17.69

1.9

1.7

19.69

20.21

nmol/l

0.57

981

7776

(3012095) Magnesium [Moles/volume] in Serum or Plasma

742

5414

1.45

17.43

4.2

3.4

0.82

mmol/l

0.49

689

5110

(3024561) Albumin [Mass/volume] in Serum or Plasma

1739

14604

1.34

17.31

5.8

5.1

35.46

35.79

g/l

1.56

1628

13685

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2285

19971

1.33

17.22

3.5

2.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

273

2.89

16.71

2.5

1.7

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

102

411

2.52

16.62

1.3

1.2

—

(3016502) Oxygen saturation in Arterial blood

479

3225

1.55

16.58

7.8

8.7

94.67

95.84

2.79

460

3116

(3030981) Hyaline casts [#/volume] in Urine by Automated count

416

2712

1.60

16.57

3.2

2.5

0.48

0.49

e6/l

0.02

409

2591

(3002582) Erythrocytes [#/volume] in Urine

1321

10704

1.35

16.52

4.4

3.3

102.46

92.45

e6/l

0.06

1068

8181

(3019309) Folate [Moles/volume] in Red Blood Cells

748

5516

1.44

16.51

1.9

1.7

1067.12

1148.09

nmol/l

1.55

552

4183

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

275

1612

1.76

16.44

1.7

1.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

593

4190

1.49

16.33

1.9

1.56

1.48

1.61

514

3710

(40768797) Stomach Pathology biopsy report

596

4223

1.48

16.18

1.3

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

543

3778

1.51

16.11

3.4

2.6

1.76

0.01

470

3359

(3036481) Cortisol [Moles/volume] in Serum or Plasma

438

2912

1.57

16.01

2.1

2.2

342.51

386.15

nmol/l

5.16

397

2701

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

232

1308

1.82

15.81

2.3

2.0

3.41

2.63

ug/l

0.19

196

1157

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

188

3.22

15.56

1.1

1.0

13.63

10.14

iu/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

204

3.12

15.48

1.3

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

108

467

2.35

15.13

2.0

1.7

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

118

531

2.26

15.07

1.7

1.2

152.50

412.44

titre

—

(3018095) Leukocytes [#/volume] in Urine

1466

12185

1.32

15.02

5.1

3.9

101.04

98.97

e6/l

0.04

1122

8627

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1772

15132

1.31

14.85

3.7

3.0

126.02

135.47

ug/l

0.74

1645

14145

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

194

3.12

14.79

2.4

2.7

664.04

521.02

e6/l

0.96

149

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

124

574

2.20

14.79

1.4

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

124

574

2.20

14.79

1.4

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

120

550

2.22

14.67

1.8

1.5

—

(3011412) CD3 cells [#/volume] in Blood

290

2.69

14.43

2.4

2.5

1291.52

1148.37

e6/l

0.75

250

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

298

1855

1.65

14.28

8.4

10.7

24.24

24.03

mmol/l

0.54

284

1813

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

188

1027

1.87

14.19

1.4

1.3

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1701

14509

1.30

14.14

2.4

2.1

95.89

96.07

pmol/l

0.05

933

7765

(3019060) Gas panel - Arterial blood

281

1728

1.67

14.11

5.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

4.01

14.04

2.3

2.0

1067.43

59330.50

u/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

540

3859

1.46

13.91

4.8

4.7

230.97

247.06

u/l

2.52

508

3644

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

168

894

1.92

13.75

1.5

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

194

3.02

13.53

2.6

2.8

208.27

230.17

e6/l

0.38

160

(3024980) IgG subclass 4 [Mass/volume] in Serum

109

497

2.23

13.52

1.6

0.73

0.80

g/l

0.27

391

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

380

2.40

13.34

1.7

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

374

2.41

13.33

1.7

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

326

2.51

13.31

1.1

1.0

0.73

0.35

u/ml

0.39

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.90

13.22

3.0

2.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

408

2787

1.52

13.11

2.7

2.3

7.78

8.29

ug/l

0.11

342

2448

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

392

2.35

12.91

1.1

2.36

3.17

0.29

(3020630) Protein [Mass/volume] in Serum or Plasma

401

2742

1.51

12.82

2.6

2.7

66.39

66.58

g/l

0.19

363

2513

(3003129) Base excess in Capillary blood by calculation

346

2.43

12.67

2.3

2.1

0.85

0.31

mmol/l

0.65

336

(3003458) Phosphate [Moles/volume] in Serum or Plasma

586

4333

1.41

12.46

7.8

6.3

1.05

1.03

mmol/l

0.92

541

4032

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.80

12.42

3.0

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.80

12.42

3.0

2.2

—

(3045414) Leukocytes [Presence] in Urine

437

3064

1.48

12.35

2.5

2.1

0.03

0.02

estimate

0.13

650

(3024522) Salmonella sp identified in Specimen by Organism specific culture

377

2.34

12.20

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

360

2.36

12.08

1.7

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

360

2.36

12.08

1.7

1.4

—

(3015736) pH of Urine

1595

13683

1.27

12.04

4.0

3.4

6.20

6.21

0.18

953

7791

(3021601) Nitrite [Presence] in Urine by Test strip

1930

16942

1.27

12.04

4.6

3.8

0.00

estimate

1.08

395

3486

(3012544) pH of Venous blood

470

3361

1.45

11.99

5.5

3.8

7.38

0.40

293

1913

(3014111) Lactate [Moles/volume] in Serum or Plasma

425

2991

1.47

11.77

7.8

8.0

1.39

1.35

mmol/l

0.32

413

2923

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

897

7158

1.33

11.70

1.3

2.06

1.75

u/ml

0.18

233

1959

(3021447) Carbon dioxide [Partial pressure] in Venous blood

459

3287

1.45

11.61

5.5

3.8

5.91

5.76

kpa

1.91

445

3203

(3035350) Ketones [Presence] in Urine by Test strip

1945

17163

1.26

11.34

4.6

3.8

7.23

4.68

estimate

0.20

396

3563

(3025468) Yersinia sp identified in Specimen by Organism specific culture

358

2.32

11.33

1.8

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

1952

17237

1.26

11.29

4.6

3.8

0.02

0.10

estimate

0.42

359

3337

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

411

2.22

11.19

1.1

1.49

1.52

g/l

0.23

378

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2483

22568

1.26

11.09

4.2

3.3

53.75

49.39

u/l

1.05

2337

21282

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

798

1.86

11.07

2.3

2.1

11.42

12.53

mg/l

0.70

138

742

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

198

1187

1.70

10.97

2.4

317.33

690.34

ug/l

1.36

187

1132

(3030467) Casts [#/volume] in Urine by Automated count

1111

9194

1.29

10.95

4.2

3.2

0.29

0.42

e6/l

2.41

857

6746

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3376

31959

1.35

10.72

25.2

15.0

24.72

25.17

mg/l

0.35

2991

26119

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2660

24417

1.26

10.70

4.7

4.1

14.78

14.74

pmol/l

0.40

2474

22440

(3022621) pH of Urine by Test strip

377

2643

1.47

10.63

3.2

2.6

6.10

6.07

0.20

272

1772

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

103

510

2.05

10.43

1.2

1.1

9.33

14.36

au/ml

0.70

144

(40760892) CBC W Ordered Manual Differential panel - Blood

876

7067

1.31

10.40

5.4

4.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1268

10721

1.27

10.39

4.5

4.2

12.80

8.51

mg/mmol

1.48

798

6841

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

225

1416

1.62

10.35

4.8

5.1

1.80

1.59

1.14

211

1336

(3002032) Base excess in Venous blood by calculation

443

3218

1.42

10.33

5.5

3.8

2.00

1.65

mmol/l

1.20

395

2792

(44806118) Parainfluenza type 4 nucleic acid detection

348

2.27

10.28

1.9

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

348

2.27

10.28

1.9

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

348

2.27

10.28

1.9

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

348

2.27

10.28

1.9

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

1265

10705

1.26

10.27

3.1

2.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.41

10.25

1.2

1.1

2.57

2.00

u/ml

0.09

(3008536) Aspergillus sp Ab [Presence] in Serum

4.91

10.25

2.6

2.8

—

(3002179) Metamyelocytes/Leukocytes in Blood

375

2651

1.46

10.13

4.7

4.5

0.56

0.73

0.84

133

816

(3017181) Myelocytes/Leukocytes in Blood

390

2780

1.45

10.08

5.0

4.7

0.83

0.92

0.31

132

861

(3048689) Calprotectin [Mass/mass] in Stool

530

3987

1.38

10.06

2.6

2.5

142.77

128.47

ug/g

0.47

433

3203

(3023520) Reticulocytes [#/volume] in Blood

404

2903

1.44

10.00

2.8

2.6

70.51

68.21

e9/l

0.73

314

2131

(3009508) Creatinine [Moles/volume] in Urine

1327

11324

1.26

9.95

3.8

3.5

7.43

7.92

mmol/l

3.55

1113

9598

(3015377) Calcium [Moles/volume] in Serum or Plasma

1306

11131

1.26

9.89

3.4

3.5

2.35

mmol/l

1.07

1168

10123

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.79

9.75

1.6

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

826

6665

1.30

9.72

1.8

1.7

53673585.80

31657816.55

pmol/l

0.47

667

5569

(3006184) Hemoglobin [Mass/volume] in Capillary blood

125

682

1.86

9.58

2.2

2.1

129.84

129.36

g/l

0.08

541

(3025941) Bacteria identified in Stool by Culture

256

1697

1.54

9.45

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

643

5030

1.33

9.44

2.5

2.2

30.01

29.74

0.53

622

4888

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

509

3852

1.37

9.29

5.4

4.9

32.20

31.89

0.26

350

2576

(36304419) Bacteria [Presence] in Urine

1051

8790

1.26

9.23

4.0

3.1

0.00

365.63

estimate

—

(3026782) Osmolality of Urine

782

6314

1.30

9.09

3.7

2.9

517.20

541.97

mosm/kgh2o

2.54

697

5547

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1327

1.60

9.08

2.1

2.4

4.21

4.20

g/l

0.08

189

1198

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1328

1.60

9.05

2.1

2.4

7.07

7.32

g/l

1.24

187

1196

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

667

5276

1.32

9.02

3.7

3.0

3.17

2.33

e6/l

0.78

357

2584

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

223

2.49

9.02

2.0

2.1

—

(3021440) Promyelocytes/Leukocytes in Blood

368

2655

1.42

8.90

5.1

4.7

0.13

0.12

0.15

112

735

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

339

2415

1.44

8.79

5.0

4.1

109.06

91.56

ng/l

1.80

288

2083

(3012516) Albumin [Mass/volume] in Urine

1231

10531

1.24

8.79

3.7

3.5

56.87

46.77

mg/l

0.64

808

6838

(3020779) Urea [Moles/volume] in Serum or Plasma

410

3032

1.39

8.60

9.7

7.7

10.20

10.00

mmol/l

0.23

397

2910

(3047181) Lactate [Moles/volume] in Blood

153

916

1.70

8.59

5.5

5.9

1.46

1.32

mmol/l

0.77

140

800

(4024509) Urine culture

217

1419

1.56

8.54

2.3

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

204

1318

1.58

8.46

2.1

1.9

37.59

40.04

u/l

1.13

186

1163

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

205

1326

1.58

8.46

2.2

2.4

3.64

3.72

g/l

0.38

185

1197

(3008152) Bicarbonate [Moles/volume] in Arterial blood

278

1921

1.48

8.45

8.1

6.8

24.75

24.22

mmol/l

1.45

265

1838

(3020874) Milk IgE Ab [Units/volume] in Serum

154

2.75

8.43

1.1

1.0

2.20

0.47

u/ml

0.52

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1250

1.59

8.37

2.2

2.4

2.86

2.89

g/l

0.16

175

1120

(3002173) Hemoglobin [Mass/volume] in Arterial blood

411

3056

1.38

8.34

9.0

9.1

122.44

121.11

g/l

0.63

397

2989

(3025159) Blasts/Leukocytes in Blood

365

2664

1.41

8.27

5.2

4.9

0.30

0.26

0.05

107

696

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

429

2.00

8.25

2.0

480.00

1180.80

titre

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

298

2.20

8.11

4.5

4.6

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

17.19

8.07

1.3

1.0

—

(3000330) Specific gravity of Urine by Test strip

242

1642

1.50

8.05

4.2

3.2

1.02

ratio

0.28

222

1494

(3017354) Segmented neutrophils/Leukocytes in Blood

345

2.11

8.04

4.3

3.8

55.22

56.23

0.14

299

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

468

1.94

8.04

1.6

1.4

25.80

13.07

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

145

872

1.69

8.03

2.0

1.7

0.23

g/l

0.40

132

827

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

120

687

1.77

7.92

1.2

1.93

3.84

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

179

1142

1.59

7.86

2.3

2.4

0.58

0.99

g/l

1.20

159

960

(1616796) Gas panel - Central venous blood

112

630

1.80

7.85

3.1

3.4

—

(3045424) Erythrocytes [Presence] in Urine

232

1572

1.50

7.78

2.6

2.2

0.00

0.52

estimate

0.52

494

(3018418) pH of Serum or Plasma

1115

9543

1.23

7.73

5.2

4.3

7.40

0.41

824

6820

(3027273) Bicarbonate [Moles/volume] in Venous blood

219

1470

1.52

7.68

4.6

3.2

25.39

25.04

mmol/l

0.70

211

1421

(3007930) Methemoglobin/Hemoglobin.total in Blood

199

1309

1.55

7.66

5.1

5.3

0.84

0.87

0.45

187

1235

(3000475) Leukocytes [#/volume] in Synovial fluid

133

792

1.70

7.65

1.7

17408.13

13965.78

e6/l

0.36

101

552

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

707

5751

1.28

7.64

3.7

2.9

1.21

1.15

e6/l

0.07

404

3057

(3019150) Specific gravity of Urine by Refractometry

905

7584

1.25

7.60

4.4

4.0

1.02

1.22

kg/l

0.50

654

5012

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

6.15

7.53

1.2

102.32

96.68

0.27

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

153

950

1.63

7.51

2.2

2.3

0.01

g/l

0.03

141

847

(3004616) Nuclear Ab [Presence] in Serum

375

2.02

7.51

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

146

898

1.65

7.45

1.3

1.2

41.53

44.52

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

963

8150

1.24

7.36

3.1

2.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.01

7.34

1.5

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.01

7.34

1.5

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1468

12978

1.21

7.26

4.4

3.7

0.04

0.25

estimate

0.65

323

2867

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

354

2629

1.38

7.24

3.5

2.6

66.82

67.76

ml/min/173m2

0.15

137

1113

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

690

5632

1.27

7.23

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

334

2.05

7.16

1.5

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1078

9264

1.22

7.08

4.2

3.2

0.00

0.25

estimate

1.19

321

2708

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

433

1.91

7.05

6.9

6.7

11.44

11.87

mg/l

0.38

407

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

137

843

1.65

7.00

1.3

12.91

6.51

u/ml

0.30

129

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

145

906

1.62

6.97

2.0

1.7

1.20

1.18

g/l

0.36

135

861

(3014051) Protein [Presence] in Urine by Test strip

1067

9189

1.22

6.82

3.7

2.9

0.00

0.05

2.19

258

(3000991) Gas panel - Venous blood

369

2795

1.35

6.67

10.5

9.4

—

(3022145) Colonoscopy Study observation

462

3619

1.31

6.63

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

206

2.30

6.59

2.2

1.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

111

657

1.71

6.58

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

135

842

1.62

6.56

1.3

1.2

2.73

3.29

u/ml

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.81

6.52

1.5

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

118

712

1.68

6.52

9.0

5.6

618.71

909.96

iu/ml

0.24

(3040151) Glucose [Moles/volume] in Capillary blood

347

1.98

6.48

6.9

5.0

7.09

7.20

mmol/l

0.13

286

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

230

1616

1.45

6.47

2.3

2.4

—

(40768443) Skin Pathology biopsy report

207

1426

1.48

6.45

1.2

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.93

6.41

2.7

2.3

4.82

4.74

kpa

0.16

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.93

6.41

2.7

2.3

9.65

10.54

kpa

1.06

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

484

3833

1.30

6.40

3.0

2.8

6.57

8.78

umol/l

2.21

406

3374

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

135

850

1.61

6.33

2.3

2.4

0.00

g/l

-0.00

127

795

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

163

1075

1.54

6.26

2.9

3.7

35.48

55.11

mg/l

1.06

141

915

(46235355) HIV 1 and 2 tests - Meaningful Use set

711

5917

1.24

6.24

2.1

1.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

173

1159

1.51

6.18

2.0

2.4

9.83

10.40

g/l

1.33

154

1019

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

134

848

1.60

6.16

1.5

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

142

912

1.58

6.14

2.2

2.3

0.00

g/l

-0.00

127

796

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.21

6.14

1.8

1.4

0.44

0.37

ug/l

0.21

(3034860) Kappa light chains.free [Mass/volume] in Serum

163

1080

1.53

6.13

2.9

3.7

58.98

58.70

mg/l

0.01

139

920

(3023420) DNA double strand Ab [Units/volume] in Serum

183

1243

1.49

6.13

1.9

1.8

13.88

7.32

iu/ml

0.46

313

(3000060) B lymphocytes [#/volume] in Blood

3.02

6.06

1.4

1.9

0.14

0.17

e9/l

0.22

(3028433) Virus identified in Specimen by Culture

3.02

6.06

1.2

—

(40758558) Short blood count panel - Blood

1103

9625

1.20

6.03

8.8

6.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

152

2.45

6.01

1.1

1.0

2.98

0.52

u/ml

0.41

(3014271) Vancomycin [Susceptibility]

146

2.48

6.01

3.8

2.7

—

(44813793) Dust mix specific IgE antibody measurement

153

2.43

5.93

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

137

881

1.57

5.90

3.8

3.4

3.51

1.97

index

0.34

453

(3024891) Influenza virus A+B Ag [Presence] in Specimen

131

834

1.59

5.89

1.2

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

146

958

1.54

5.76

2.8

3.6

3.12

4.25

ratio

0.35

564

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

343

1.91

5.67

1.4

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

360

2786

1.32

5.64

4.8

3.1

4.85

4.60

kpa

0.92

347

2708

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3074

29356

1.20

5.52

5.9

5.1

1.83

1.91

mu/l

3.28

2872

27186

(3004809) Band form neutrophils/Leukocytes in Blood

522

1.72

5.52

5.3

3.9

1.46

1.44

0.02

468

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

404

3195

1.29

5.40

2.5

2.2

0.21

g/l

0.37

383

2975

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

216

1556

1.41

5.35

1.8

1.7

1.38

1.52

g/l

1.74

183

1316

(3029937) Albumin [Presence] in Urine by Test strip

1067

9376

1.19

5.29

4.4

4.0

0.00

estimate

0.15

346

3155

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

244

1809

1.37

5.10

10.7

11.2

16.03

0.00

235

1745

(3000570) Elastase.pancreatic [Mass/mass] in Stool

144

969

1.50

5.10

1.5

1.4

232.76

278.49

ug/g

2.16

552

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

153

1043

1.49

5.09

1.6

1.5

0.43

0.18

iu/ml

0.32

190

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

156

1068

1.48

5.08

5.5

3.5

0.35

0.33

iu/ml

0.23

599

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1667

15223

1.16

5.08

3.3

2.8

—

estimate

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

289

2203

1.34

5.05

2.5

16.12

20.19

au/ml

0.62

267

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

199

2.12

4.97

2.5

3.0

37.19

39.53

0.34

(3037121) Protein [Mass/volume] in Urine

164

1140

1.46

4.95

3.5

3.2

333.94

439.14

mg/l

0.61

520

(3027456) Digoxin [Moles/volume] in Serum or Plasma

102

641

1.61

4.90

3.6

3.2

0.86

0.79

nmol/l

0.42

504

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3204

30816

1.19

4.83

21.0

14.9

80.90

81.49

ml/min/173m2

0.82

3007

28560

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

113

2.49

4.78

1.4

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

285

1.91

4.77

2.1

1.5

1.53

1.17

promille

0.76

219

(3051387) C reactive protein [Mass/volume] in Capillary blood

108

693

1.57

4.77

5.4

3.2

24.40

27.73

mg/l

0.40

474

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

546

1.64

4.72

4.6

2.8

1622.60

1641.53

u/ml

—

(3010838) Calcium [Moles/time] in 24 hour Urine

519

1.65

4.60

1.7

1.9

4.70

4.99

mmol/24h

0.38

463

(4146454) Self-monitoring of blood glucose

354

1.79

4.59

2.4

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

289

1.88

4.59

2.9

2.8

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

115

758

1.53

4.53

1.8

1.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

397

3208

1.26

4.49

2.9

2.5

36.61

54.36

u/l

0.60

345

2722

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

215

1597

1.37

4.48

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

154

1080

1.44

4.47

1.9

1.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

264

2026

1.32

4.44

1.4

1.3

35.56

61.48

au/ml

—

148

(3027923) C peptide [Moles/volume] in Serum or Plasma

189

2.07

4.39

1.9

1.4

1.31

1.22

nmol/l

0.17

133

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

250

1910

1.33

4.34

3.1

3.5

4.45

4.48

pmol/l

0.27

225

1698

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

372

1.73

4.19

1.2

—

(3011985) Renin [Units/volume] in Plasma

449

1.66

4.14

1.3

1.4

72.88

66.59

mu/l

0.08

401

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

598

1.57

4.12

1.2

1.3

64.88

31.83

u/l

0.67

514

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

137

956

1.45

4.12

3.5

2.8

3.82

3.56

g/l

0.92

130

915

(3049717) Cytology report of Urine Cyto stain

171

1242

1.39

4.11

2.5

2.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

383

1.71

4.06

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

453

1.65

4.02

7.0

5.7

339.76

366.08

umol/l

0.91

398

(3010144) Erythrocytes [#/volume] in Synovial fluid

303

1.79

4.00

1.6

1.4

119902.75

95382.07

e6/l

0.09

208

(3052592) Norovirus Ag [Presence] in Stool

3.13

3.92

1.5

1.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

157

1135

1.40

3.90

1.3

1.2

0.18

0.74

u/ml

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

7.28

3.85

1.4

1.5

1.35

3.06

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

7.28

3.85

1.4

1.5

1.10

0.69

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

7.28

3.85

1.4

1.5

1.12

3.75

mg/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

443

1.64

3.85

1.5

1.4

0.60

4.56

nmol/l

0.50

430

(3004119) Hemoglobin [Mass/volume] in Venous blood

268

2109

1.29

3.78

4.7

3.2

128.53

129.54

g/l

0.29

258

2054

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

555

1.56

3.78

1.1

13.00

1175.80

iu/ml

0.54

114

(3015076) Soybean IgE Ab [Units/volume] in Serum

140

2.15

3.76

1.1

1.0

0.84

3.61

u/ml

0.35

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

645

1.52

3.73

1.2

38.09

39.39

u/ml

0.03

(3044242) Glucose [Moles/volume] in Arterial blood

174

2.02

3.73

1.7

2.0

8.75

8.48

mmol/l

0.08

174

(3006270) Folate [Moles/volume] in Blood

259

1.82

3.71

1.2

384.33

362.37

nmol/l

0.26

227

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3139

30324

1.16

3.67

7.5

6.1

40.12

39.21

mmol/mol

4.78

2959

28459

(3045716) Anion gap in Serum or Plasma by calculation

312

1.74

3.65

3.4

10.59

11.10

mmol/l

0.34

304

(3020876) Protein [Mass/time] in 24 hour Urine

380

1.67

3.65

2.4

2.5

1.18

1.39

g/24h

0.31

215

(44816559) Phosphatidylethanol [Mass/volume] in Blood

196

1485

1.34

3.65

1.9

1.8

0.30

0.33

mg/l

0.21

733

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

149

2.09

3.62

1.2

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

451

3787

1.21

3.60

8.1

6.9

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

104

2.32

3.59

1.5

1.3

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

219

1.88

3.58

1.3

10.42

12.11

u/l

0.52

207

(3016228) CD19 cells/cells in Blood

130

2.16

3.57

2.2

2.0

9.96

9.10

0.09

124

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

2.57

3.54

1.0

1.1

8.69

12.01

u/ml

0.35

(21494814) CD8 cells/Lymphocytes in Specimen

131

2.15

3.50

2.1

2.0

27.57

30.75

0.51

131

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

131

2.15

3.50

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

131

2.15

3.50

1.6

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

200

1.91

3.47

1.5

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

104

714

1.47

3.46

2.5

3.0

32.27

36.32

umol/l

1.01

649

(1761482) Bacteria [#/volume] in Urine by Culture

114

797

1.44

3.45

4.9

3.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

173

1.97

3.43

2.1

1.9

106.14

114.53

ng/l

0.20

173

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

426

1.61

3.42

1.3

1.4

284.60

287.29

pmol/l

0.03

364

(3039000) Anion gap in Blood by calculation

626

1.50

3.41

6.2

7.3

11.63

11.47

mmol/l

0.15

563

(3018572) Chloride [Moles/volume] in Blood

627

1.49

3.39

6.2

7.3

104.57

105.37

mmol/l

0.86

564

(3042733) HLA Ab [Presence] in Serum

114

2.20

3.34

3.5

4.8

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

3351

32591

1.17

3.33

27.1

17.9

139.52

139.67

mmol/l

3.01

3310

31934

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

184

1.91

3.23

1.3

—

201.67

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

668

1.46

3.20

1.6

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

319

1.67

3.14

1.9

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

158

1.97

3.13

2.6

2.5

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

336

1.65

3.09

1.4

1.6

66.30

59.24

0.67

214

(3020393) Adenovirus Ag [Presence] in Stool

3.67

3.08

1.3

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

224

1.79

3.06

1.6

1.5

85.58

81.79

umol/l

0.20

224

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

195

1.85

3.06

1.5

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

384

1.60

3.05

1.4

0.18

0.23

nmol/l

0.56

312

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

264

2135

1.25

3.04

10.5

10.3

1.47

1.27

2.21

264

2119

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

5.84

3.02

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

196

1.84

3.01

1.5

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3160

30664

1.14

2.99

5.8

4.9

6.07

5.95

mmol/l

4.05

2922

28233

(3021589) Normoblasts [#/volume] in Blood

1522

14171

1.12

2.97

14.1

11.1

0.00

e9/l

0.75

1251

11532

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

379

1.59

2.97

1.6

1.4

—

nmol/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

137

1018

1.36

2.96

1.4

1.2

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

255

2062

1.25

2.94

10.8

10.6

0.66

0.65

0.19

255

2044

(3035637) Corticotropin [Mass/volume] in Plasma

372

1.59

2.94

1.3

1.6

21.91

28.37

ng/l

0.99

372

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

198

1.83

2.93

1.5

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.10

2.88

7.9

4.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

156

1188

1.33

2.88

1.6

1.7

12.27

14.42

u/ml

0.24

291

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.59

2.87

1.0

1.1

0.80

0.65

umol/24h

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

171

1.88

2.85

1.3

1.1

—

(3012501) Base excess in Blood by calculation

627

1.45

2.84

3.1

3.6

2.54

2.45

mmol/l

0.10

391

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

172

1.87

2.80

1.1

1.5

—

(40757373) Influenza virus identified in Isolate

2.55

2.78

2.0

1.3

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3351

32688

1.15

2.77

27.4

18.0

3.98

mmol/l

0.34

3307

31968

(3017446) Testosterone [Moles/volume] in Serum or Plasma

413

3529

1.19

2.77

2.5

2.3

13.28

13.73

nmol/l

0.60

372

3252

(3000093) Morphology [Interpretation] in Blood Narrative

300

1.64

2.76

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

689

1.42

2.76

3.6

1.9

0.99

0.86

nmol/l

0.87

594

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

145

1.94

2.74

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

5.01

2.72

1.9

1.8

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

101

725

1.40

2.72

2.2

144.78

93.88

ug/min

0.35

444

(3045142) Bone marrow Pathology biopsy report

380

1.56

2.71

1.2

1.4

—

(36660697) Celiac disease serology panel - Serum

299

2484

1.22

2.71

1.2

—

(40768446) Kidney Pathology biopsy report

125

2.01

2.70

1.6

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

577

1.45

2.67

3.7

3.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

449

3879

1.18

2.66

1.9

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

133

1.96

2.64

2.5

2.0

134.63

131.79

umol/l

0.02

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

136

1030

1.33

2.63

3.4

3.3

1.55

1.51

mg/l

0.23

122

945

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

115

850

1.36

2.61

1.2

1.3

447.87

541.07

mg/l

2.17

108

811

(3006653) Thiamine [Moles/volume] in Blood

170

1.83

2.58

1.2

134.42

135.34

nmol/l

0.04

170

(3017569) Oxygen content in Arterial blood

149

1.89

2.55

1.8

2.0

14.89

16.04

1.33

149

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

149

1.89

2.55

1.1

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

141

1079

1.32

2.55

2.8

2.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.36

2.55

1.1

1.5

1.16

1.17

mmol/l

0.21

(3051611) Lipemic interference index of Serum or Plasma

307

1.60

2.55

3.4

3.5

12.03

13.15

index

0.49

177

(3035947) Staphylolysin Ab [Units/volume] in Serum

150

1.87

2.51

1.4

1.1

3.40

4.80

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

114

850

1.35

2.47

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

545

1.44

2.47

2.0

1.7

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

144

1.88

2.45

1.7

2.48

2.53

u/field

0.01

102

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.13

2.43

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

182

1.76

2.39

1.9

3.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

126

960

1.32

2.37

1.3

180.05

218.01

miu/ml

0.67

420

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

6.26

2.37

1.6

1.4

—

(3028300) Cannabinoids [Presence] in Urine

174

1385

1.27

2.36

2.7

2.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

114

859

1.34

2.32

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

611

1.40

2.32

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

173

1380

1.26

2.31

2.6

2.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

119

1.94

2.30

2.6

1.8

38.83

40.63

g/l

0.40

119

(3014765) Yersinia sp identified in Stool by Organism specific culture

113

852

1.34

2.30

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

255

2125

1.21

2.28

1.2

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.12

2.28

1.2

35.66

39.26

g/l

—

(3035880) pH of Pleural fluid

163

1.78

2.26

1.1

1.3

7.45

7.40

1.39

113

(3016879) Cocaine [Presence] in Urine

161

1278

1.27

2.25

2.7

2.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

384

3333

1.17

2.18

3.7

4.4

29.58

22.79

ug/l

0.12

326

2694

(3000764) Benzodiazepines [Presence] in Urine

171

1374

1.26

2.17

2.6

2.4

—

(21494755) Public health laboratory ask at order entry panel

289

3391

0.84

2.16

1.4

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

211

1.66

2.16

1.4

23.25

19.27

u/ml

—

(3011288) Drugs identified in Urine by Screen method Nominal

120

923

1.31

2.14

5.8

3.7

—

(3003740) Influenza virus B Ag [Presence] in Specimen

613

1.38

2.12

1.2

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

315

1.53

2.10

1.9

2.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

117

1.88

2.05

2.1

2.2

9.52

9.32

mg/l

0.06

101

(3036782) Glucose [Moles/volume] in Pleural fluid

317

1.52

2.05

1.3

1.4

6.42

6.30

mmol/l

0.12

297

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.03

2.05

1.2

1.3

306.46

565.03

ug/l

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

318

1.52

2.03

1.4

1.2

59.86

66.54

u/l

0.39

277

(3024869) Neuronal Ab [Presence] in Serum

2.40

2.02

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

121

941

1.29

2.01

2.9

2.7

197.03

191.64

0.27

116

896

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.08

2.01

1.7

2.9

—

(4195642) Thrombophilia screening test

484

1.41

2.00

1.2

—

(3017509) Phencyclidine [Presence] in Urine

2.82

2.00

1.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

410

1.45

1.98

1.1

—

(3044927) Protein electrophoresis panel - Urine

320

1.51

1.98

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

186

1.67

1.97

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

752

1.32

1.96

1.2

1.3

3.84

3.77

mmol/l

0.28

705

(3027944) Amphetamines [Presence] in Urine

167

1356

1.24

1.96

1.9

2.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

690

0.68

1.93

1.3

1.5

61.45

60.83

ug/l

0.02

556

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

113

1.86

1.91

1.2

—

(3002619) Bacteria identified in Specimen by Culture

2.25

1.90

1.5

1.2

—

(3033099) Centromere Ab [Titer] in Serum

2.25

1.90

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

106

1.89

1.90

2.4

1.7

49.72

67.76

ug/l

0.57

101

(3021879) Hepatitis B virus core Ab [Presence] in Serum

307

2650

1.17

1.90

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

102

783

1.31

1.89

1.1

7.90

6.17

eliau/ml

—

103

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

507

1.39

1.89

1.4

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

158

1.71

1.88

1.0

1.2

—

(40762814) Titanium [Mass/volume] in Blood

2.31

1.87

2.3

2.4

3.74

4.75

ug/l

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

228

1.58

1.87

1.1

1.0

738.67

735.47

ng/l

0.01

148

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

646

1.34

1.85

1.4

1.2

228.04

256.86

u/ml

0.51

419

(3011397) Hemoglobin [Presence] in Urine by Test strip

839

7741

1.11

1.84

4.1

3.7

0.00

0.15

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

269

1.53

1.83

2.1

0.97

1.68

u/field

1.29

142

(3041672) Baker's yeast Ab [Presence] in Serum

3.53

1.83

1.0

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.76

1.83

1.2

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

911

8443

1.10

1.82

5.1

4.2

89.04

88.46

0.28

888

8260

(40758292) HTLV I+II Ab panel - Serum

2.12

1.81

1.4

—

(3024471) HLA-A [Type]

108

1.86

1.81

1.1

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

230

1.57

1.81

1.1

1.0

353.92

309.53

ng/l

0.27

155

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.27

1.80

1.3

1.2

—

(3024263) Appearance of Synovial fluid

168

1.67

1.80

1.8

1.9

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.76

1.79

2.3

2.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

231

1.56

1.78

1.1

1.0

52.54

41.71

ng/l

0.41

152

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

642

0.68

1.78

1.3

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

200

1.60

1.76

1.3

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

1.87

1.76

2.3

2.0

2.39

1.52

ratio

1.19

(3036489) Thrombin time

152

1239

1.24

1.75

2.6

2.2

21.74

20.90

0.43

136

1101

(3003434) Protein [Mass/volume] in Pleural fluid

438

1.40

1.75

1.5

33.86

31.44

g/l

0.81

392

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

115

908

1.27

1.74

1.8

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.50

1.73

1.2

1.3

—

581.16

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

1.73

1.2

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.23

1.73

1.8

1.4

—

9350.00

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

650

0.69

1.73

1.3

1.5

1.24

1.18

ratio

0.09

380

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

650

0.69

1.73

1.3

1.5

0.93

0.96

ratio

0.28

380

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

650

0.69

1.73

1.3

1.5

1.01

1.19

ratio

0.69

382

(3043238) Trisomy 21 risk [Likelihood] in Fetus

567

0.67

1.73

1.3

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

689

1.31

1.72

4.6

3.0

6.95

7.70

mmol/l

2.50

667

(3023511) Choriogonadotropin [Units/volume] in Urine

482

1.38

1.72

1.7

1.3

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

2.92

1.72

4.0

4.7

1.89

0.96

mg/l

—

(3037756) Immunofixation for Serum or Plasma

672

1.32

1.72

2.1

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

163

1.66

1.71

1.5

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

163

1.66

1.71

1.5

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

360

3177

1.15

1.68

2.3

2.0

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

111

1.81

1.68

2.9

2.8

24.15

29.59

umol/l

1.22

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3088

30208

1.10

1.68

4.8

4.2

1.36

1.31

mmol/l

3.70

2864

27990

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

737

1.30

1.66

1.2

1.4

5.96

30.76

e6/l

1.36

543

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.58

1.65

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

164

0.43

1.65

1.7

1.6

—

(3001729) Color of Synovial fluid

2.80

1.65

2.3

1.6

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.53

1.64

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

228

1.54

1.64

1.2

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

127

1.74

1.63

1.3

156.77

176.47

mmol/24h

0.56

127

(3035933) Granulocytes/Leukocytes in Blood

670

1.30

1.62

2.9

3.3

59.84

57.77

0.84

670

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

221

1.54

1.62

1.2

1.1

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.57

1.61

6.2

5.0

263.60

500.86

umol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

336

1.43

1.60

2.1

7.56

9.20

umol/l

0.23

246

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

750

1.29

1.60

1.3

1.4

528.64

845.58

e6/l

0.37

591

(3008898) HLA-B27 [Presence]

127

1027

1.24

1.60

1.1

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1151

0.78

1.60

1.4

1.6

883.20

1027.18

mu/l

0.87

925

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.50

1.59

1.1

1.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.07

1.59

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

167

1.62

1.58

1.1

—

(3003181) Sodium [Moles/volume] in Urine

568

1.33

1.57

1.4

60.38

61.56

mmol/l

0.10

459

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

104

824

1.27

1.56

1.6

2.1

574.41

3.81

iu/l

0.49

332

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.93

1.54

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.43

1.53

1.3

1.5

—

(3002256) Pathology report gross observation

477

4316

1.12

1.52

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

391

1.39

1.51

1.5

1.4

1965.93

3720.19

e6/l

0.36

277

(3005033) Fetal Nuchal fold Thickness US

549

0.69

1.50

1.3

1.5

1.26

1.27

0.03

374

(3032773) Endomysium IgG Ab [Titer] in Serum

291

1.45

1.50

1.2

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.86

1.50

1.7

1.3

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

695

6421

1.10

1.49

3.0

2.45

mmol/l

0.61

619

5742

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

226

1.51

1.48

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

226

1.51

1.48

1.2

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.00

1.48

2.0

15.89

16.68

umol/l

0.11

(3043409) Potassium [Moles/volume] in Arterial blood

107

859

1.25

1.46

5.7

4.1

3.91

mmol/l

0.01

107

850

(3047352) Trisomy 18 risk [Likelihood] in Fetus

557

0.70

1.45

1.3

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.37

1.45

1.1

1.0

—

(3012441) Differential panel - Pleural fluid

335

1.41

1.45

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

559

1.31

1.44

1.7

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.88

1.44

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.12

1.44

1.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

745

1.27

1.43

1.3

1.2

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.73

1.43

1.0

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

555

5082

1.11

1.43

1.7

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

370

1.38

1.43

2.2

2.1

20.67

22.40

mg/l

0.15

129

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

371

1.38

1.41

2.7

2.5

13.84

38.82

iu/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.25

1.40

1.3

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

416

1.35

1.37

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

170

1442

1.19

1.37

1.3

1.4

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.94

1.36

1.2

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.94

1.36

1.2

1.0

—

(3018333) Ribosomal P Ab [Presence] in Serum

215

1.49

1.35

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

409

1.35

1.34

1.1

1.3

15.40

24.18

u/l

2.08

338

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

180

1538

1.18

1.34

2.7

2.0

—

(3024932) HLA-DR beta [Type]

105

1.72

1.33

1.1

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

274

1.43

1.32

1.6

1.5

28.50

29.24

0.05

174

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

283

1.42

1.31

1.1

281.83

284.18

mg/l

0.09

262

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

125

1039

1.21

1.27

3.3

2.3

591.96

5811.95

u/l

6.16

420

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

345

1.37

1.26

1.1

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

141

1187

1.19

1.26

1.8

—

16.85

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

219

1.46

1.25

1.2

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

528

1.29

1.25

1.1

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.40

1.24

1.2

1.4

5.85

5.94

mmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

2.40

1.24

1.2

1.0

—

(3025130) Human papilloma virus identified in Specimen

389

1.34

1.24

2.0

1.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

386

3499

1.11

1.23

2.5

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.91

1.22

1.9

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

262

1.42

1.22

1.3

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.63

1.21

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

417

1.32

1.21

1.0

1.1

1.33

2.52

eliau/ml

2.78

204

(40768806) Pleura Pathology biopsy report

331

1.36

1.20

1.5

1.6

—

(21494434) Karyotype in Bone marrow

280

1.40

1.20

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

156

1.54

1.20

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

109

1.65

1.18

2.9

1.7

1.38

1.80

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.11

1.18

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

181

1.49

1.18

1.0

—

(3025577) Chromium [Mass/volume] in Blood

181

1.49

1.18

2.4

2.1

2.74

1.93

ug/l

0.58

153

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

125

1.60

1.17

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.50

1.15

1.0

1.1

—

16.38

iu/ml

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

474

1.29

1.14

1.1

114.84

113.51

0.10

436

(3050129) First trimester maternal screen panel - Serum or Plasma

777

0.78

1.13

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.75

1.12

1.1

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.34

1.12

2.6

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

159

1.51

1.11

1.5

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.71

1.11

1.2

1.1

—

(3005570) Glucose [Moles/volume] in Urine

319

1.35

1.11

1.7

1.9

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

619

1.25

1.10

1.7

1.4

150.96

152.40

au/ml

0.04

183

(3000034) Microalbumin [Mass/volume] in Urine

251

1.40

1.10

3.2

3.3

155.97

33.03

mg/l

0.83

192

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

133

1132

1.18

1.08

1.9

214.25

212.55

pmol/l

0.07

127

1072

(3023383) Lactate [Moles/volume] in Pleural fluid

1.69

1.07

1.3

1.4

3.40

3.44

mmol/l

0.01

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.76

1.06

1.9

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

361

3292

1.11

1.05

3.8

3.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

359

3926

0.91

1.03

2.1

2.0

3.65

3.62

ratio

0.16

281

3037

(3010375) cycloSPORINE [Mass/volume] in Blood

154

1.50

1.03

30.8

23.7

94.39

111.09

ug/l

0.62

122

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

382

3504

1.10

1.00

1.4

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

782

1.21

1.00

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.62

0.99

1.0

1.1

—

(1002224) Polysomnography panel

189

1666

1.14

0.99

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

230

2054

1.13

0.99

1.3

1.2

125.27

143.18

u/ml

0.31

743

(3009214) Lutropin [Units/volume] in Serum or Plasma

119

1013

1.18

0.99

1.4

8.20

8.58

u/l

0.13

828

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.97

0.0

1.0

—

(4198724) Urine methamphetamine measurement

165

1.46

0.96

1.8

3.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.96

0.0

1.1

—

67.45

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3434

33946

1.08

0.96

14.9

11.6

27.51

27.45

u/l

0.06

3362

32974

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

182

1.43

0.95

1.0

1.1

0.99

1.14

u/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

109

1280

0.85

0.95

1.1

0.68

0.64

ratio

0.27

157

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

116

1354

0.85

0.94

1.1

1.48

1.50

g/l

0.38

116

1354

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.14

0.91

1.0

1.1

0.08

0.02

u/ml

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3205

31623

1.07

0.90

5.6

4.9

1.38

1.42

mmol/l

7.93

3008

29529

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

167

1472

1.14

0.90

3.2

3.5

68.19

77.48

u/ml

0.14

157

1429

(3044290) Cell count panel - Cerebral spinal fluid

691

1.21

0.90

1.1

1.4

—

(1761868) Lipid panel - Serum or Plasma

1257

13048

0.95

0.89

3.4

3.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

236

1.36

0.89

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.65

0.88

1.2

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

307

1.31

0.87

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.00

0.87

1.8

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

370

1.27

0.85

1.2

1.1

93.85

96.23

0.21

353

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3224

31835

1.06

0.85

5.6

5.0

4.53

4.61

mmol/l

4.58

3037

29899

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

187

1.39

0.85

9.5

7.7

43.50

14265.00

u/ml

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

145

1.45

0.84

3.0

2.4

56.06

50.91

umol/l

0.28

125

(4212803) Bone marrow aspirate examination

1.94

0.84

1.2

1.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

276

2518

1.10

0.84

3.4

3.9

1.22

1.23

mmol/l

0.67

242

2180

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

129

1.47

0.83

3.5

3.0

0.61

mmol/l

0.07

129

(3044007) Cell count panel - Peritoneal fluid

115

0.52

0.82

1.5

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

284

1.31

0.81

1.3

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.55

0.81

1.1

1.2

80.20

84.33

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.55

0.81

1.5

1.6

62.93

114.90

nmol/24h

2.67

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

258

1.32

0.81

1.2

110.47

106.27

pmol/l

0.18

258

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

302

1.29

0.81

1.1

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

155

1.42

0.81

1.2

1.1

—

8.88

u/ml

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

311

1.29

0.80

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

312

1.28

0.79

1.2

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.67

0.78

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

156

1.41

0.78

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

225

1.34

0.78

1.5

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

349

1.26

0.77

1.5

1.4

48258.68

75910.04

e6/l

0.35

203

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

174

1.38

0.76

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.77

0.76

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

503

1.22

0.76

1.2

2.00

3.06

u/ml

0.88

180

(3051101) Glucose [Moles/volume] in Cord blood

1.70

0.75

4.0

6.4

7.83

8.29

mmol/l

—

(3045788) Cell count panel - Pleural fluid

315

1.27

0.74

1.4

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

2.08

0.74

1.8

2.5

3.02

3.56

mg/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.80

0.72

1.1

1.2

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.61

0.72

2.3

2.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.61

0.72

1.8

3.3

73.01

90.97

ng/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.52

0.72

1.1

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3462

34303

1.07

0.72

28.9

19.6

81.24

79.46

umol/l

1.90

3432

33894

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

1.67

0.72

1.3

1.2

31.32

77.96

ng/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

267

2898

0.92

0.71

1.7

3.37

3.50

mmol/l

0.98

183

1992

(3039443) Prostate specific Ag panel - Serum or Plasma

840

1.16

0.71

1.4

1.6

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.75

0.71

1.0

1.1

6.63

6.95

u/ml

—

(3047189) Immunofixation for 24 hour Urine

151

1.39

0.71

2.0

1.6

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.92

0.70

2.0

2.4

0.60

0.73

u/field

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

508

1.20

0.70

1.1

—

(4038314) Semen analysis, post vasectomy

1.85

0.68

1.0

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.56

0.68

8.5

6.7

66.67

69.53

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.68

1.1

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.60

0.68

1.1

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.60

0.68

1.2

1.0

30.45

35.81

iu/ml

0.14

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

120

0.58

0.67

5.4

6.5

7.43

8.20

—

120

(40761995) Spermatozoa Progressive [#/volume] in Semen

120

0.58

0.67

2.7

3.2

31.00

44.24

—

120

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1266

12272

1.05

0.67

5.0

5.1

3.02

3.14

ug/l

0.05

1157

11173

(3000012) Reticulocyte production index

473

0.80

0.66

1.6

2.2

0.91

0.87

0.23

328

(3003694) ABO and Rh group [Type] in Blood

920

9551

0.95

0.66

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

323

3009

1.08

0.66

1.8

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.51

0.66

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

128

1.41

0.65

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

190

0.68

0.65

6.0

7.6

1710.40

172.08

ug/l

—

136

(3001556) Androgen free Index in Serum or Plasma

1.72

0.64

1.0

1.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

425

0.80

0.62

3.5

2.4

13.20

13.13

0.17

420

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.52

0.62

1.4

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

109

964

1.13

0.62

1.2

1.3

111.25

109.05

titre

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

963

0.87

0.61

1.4

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.60

0.61

12.9

13.7

5.01

5.70

mmol/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

191

1.31

0.60

1.4

1.6

6.05

6.97

u/l

0.17

156

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.60

0.0

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

1.57

0.60

1.0

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2628

26642

0.96

0.60

27.3

18.7

13.77

13.58

10.79

2605

26247

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

603

1.16

0.58

1.1

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.56

0.58

3.2

1.8

—

(4034850) Laboratory test

969

0.87

0.58

15.8

10.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.58

0.0

1.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

237

1.27

0.58

1.2

1.1

14.44

20.21

u/ml

0.55

105

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

161

0.68

0.57

1.2

9.91

8.84

mm/h

0.25

161

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

201

1851

1.09

0.56

2.8

2.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.67

0.56

1.0

1.1

1.51

1.74

umol/24h

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.56

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

229

1.27

0.56

2.5

2.1

631.27

616.64

0.09

150

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

297

0.77

0.56

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.56

1.6

1.4

8.80

9.03

ug/l

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

384

1.20

0.55

1.3

7.09

7.18

mmol/l

0.08

333

(3020491) Glucose [Moles/volume] in Blood

239

1.26

0.55

1.3

2.1

8.00

6.68

mmol/l

0.80

161

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

505

1.17

0.54

1.1

1.2

3.79

4.55

u/ml

0.27

246

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.42

0.54

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.49

0.53

1.1

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2709

27416

0.96

0.53

28.9

19.3

332.21

333.01

g/l

4.35

2697

27230

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.45

0.53

5.9

7.2

12.17

10.51

—

(3034770) Mitochondria Ab [Titer] in Serum

105

941

1.12

0.51

1.2

—

1311.67

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.50

0.51

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

752

1.13

0.51

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

109

1.38

0.50

1.2

1.1

—

5.40

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

1.46

0.50

1.0

1.9

—

(40768800) Prostate Pathology biopsy report

712

0.87

0.49

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3255

32280

1.04

0.49

6.1

5.6

2.66

2.72

mmol/l

2.98

3059

30178

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

137

1.32

0.47

1.1

1063.00

240.91

ng/l

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

127

1159

1.10

0.46

1.7

253.32

284.29

mu/l

1.07

117

1070

(4035726) Immunohistochemistry procedure

297

2806

1.06

0.45

1.5

1.4

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

666

1.13

0.45

1.7

1.9

—

(3004451) EKG impression Narrative

183

1.26

0.44

1.3

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

121

1.32

0.44

1.1

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

480

0.85

0.43

2.1

1.8

—

(3020650) Glucose [Presence] in Urine

127

0.71

0.43

1.6

1.8

0.00

0.05

estimate

—

127

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

157

1.28

0.43

1.1

1.2

—

71.29

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.43

0.42

2.4

2.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

230

1.22

0.42

2.0

1.3

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

131

1.30

0.42

1.1

1.0

90.67

94.39

0.24

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.36

0.41

1.2

89.46

101.11

0.43

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.39

0.40

6.1

7.0

6.37

5.31

kpa

0.56

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.47

0.40

1.2

1.1

—

(3006462) Nitrate [Presence] in Urine

132

1.29

0.40

6.4

3.5

—

(3008295) Osmolality of Serum or Plasma

352

1.17

0.40

1.5

1.4

278.52

279.28

mosm/kgh2o

0.08

266

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

150

1.27

0.40

1.2

1.1

—

(3043410) Blood group antigens tested for on Red Blood Cells

101

0.69

0.39

1.1

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

193

0.78

0.39

1.9

1.8

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.2

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

271

1.18

0.37

1.2

1.1

—

(21491868) Cryoglobulin [Mass/volume] in Serum

113

0.71

0.37

1.3

1.2

—

0.24

g/l

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.30

0.37

1.4

3.1

3.22

501.53

ug/l

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

152

1.25

0.37

1.4

1.3

5.70

5.77

mmol/l

0.14

144

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

320

0.84

0.35

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

709

1.10

0.34

4.0

3.8

285.88

1070.54

u/ml

0.96

655

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

121

1123

1.08

0.34

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.32

0.33

3.0

1.2

18.21

16.08

umol/l

0.60

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.28

0.32

1.0

2.0

1.02

1.41

mg/l

—

(3016038) Potassium [Moles/volume] in Urine

201

1.20

0.32

1.6

1.1

39.76

34.33

mmol/l

0.53

179

(4133840) Spirometry

1.33

0.32

1.4

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

1.25

0.30

1.1

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

722

7394

0.97

0.29

3.0

3.1

0.76

0.77

ug/l

0.07

429

4519

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1367

13468

1.02

0.27

2.0

1.9

1.46

1.39

mmol/l

1.74

1160

11437

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.23

0.27

1.3

—

118.60

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.26

0.26

2.2

1.8

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.25

0.25

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

235

1.15

0.25

1.1

—

0.62

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

179

1.17

0.25

1.2

1.4

5.53

6.90

u/l

1.05

154

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

129

1220

1.06

0.24

2.4

3.4

2006.18

3803.88

u/ml

0.27

104

1064

(4281824) Cell count and differential, peritoneal fluid

321

1.12

0.24

1.1

—

(44806420) Estimation of glomerular filtration rate

339

0.88

0.24

2.9

2.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

171

1.17

0.23

1.4

1.1

—

(3034092) Cytoplasmic Ig cells/cells in Blood

1.28

0.23

13.4

6.0

0.30

0.23

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.28

0.23

1.2

1.7

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.22

0.22

1.0

2.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.22

0.22

1.2

1.1

—

(3017704) Immunofixation for Urine

178

0.84

0.22

2.9

1.6

—

(3014891) Appearance of Pleural fluid

1.19

0.21

2.8

1.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.1

—

1.31

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40768441) Liver Pathology biopsy report

251

0.88

0.20

1.4

1.5

—

(40768793) Breast Pathology biopsy report

697

0.93

0.20

1.5

1.4

—

(40765096) Chromosome analysis panel by Banding

115

0.78

0.20

1.2

1.1

—

(3023410) Appearance of Cerebral spinal fluid

336

1.10

0.19

1.4

1.6

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

472

1.08

0.19

1.6

1.4

0.45

0.38

nmol/l

0.16

376

(4211845) Urine protein measurement

147

1.16

0.18

6.4

3.4

—

(3011436) Histone Ab [Units/volume] in Serum

1.13

0.17

1.1

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

161

1551

1.04

0.17

1.5

1.6

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.73

0.17

1.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.73

0.17

1.0

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

148

1.15

0.16

1.8

6.4

60.27

68.13

mg/l

0.20

103

(4094501) Cardiovascular stress test using bicycle ergometer

934

0.95

0.16

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.21

0.15

1.5

1.3

—

0.24

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.19

0.14

1.2

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.19

0.14

1.2

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.19

0.14

1.2

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.19

0.14

1.2

1.0

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

189

1.11

0.13

1.1

1.2

0.48

0.56

ratio

1.73

101

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

149

0.87

0.13

1.3

1.6

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

550

0.94

0.13

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

221

1.09

0.11

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

115

0.87

0.10

1.1

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

166

0.90

0.09

1.1

1417.07

1523.09

miu/ml

0.14

166

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

321

1.06

0.09

1.3

1.4

141.96

198.62

pmol/l

1.07

321

(3029396) Erythrocyte agglutination [Presence] in Blood

1.08

0.08

1.9

2.9

—

(40768795) Lymph node Pathology biopsy report

313

1.05

0.07

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

123

1204

1.02

0.07

2.1

1.7

5.57

4.27

mg/l

0.57

102

878

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.02

0.07

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

121

0.91

0.06

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

987

9820

1.01

0.06

4.0

4.2

22.61

22.02

0.54

431

4481

(3009871) Measles virus Ab [Titer] in Serum

129

1.09

0.05

1.5

1.6

2853.33

3320.00

titre

—

(40761536) Microorganisms panel - Urine sediment

249

2518

0.99

0.05

4.5

3.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

366

1.04

0.05

2.3

1.7

332.74

336.81

mu/l

0.03

297

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

150

1.07

0.04

9.2

3.7

0.78

1.40

2.06

150

(3034426) Prothrombin time (PT)

111

1.08

0.04

1.2

27.75

28.83

0.40

111

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

162

1.05

0.02

2.6

2.0

1399.20

143.61

ug/min

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

1.07

0.02

1.1

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

297

0.98

0.01

3.7

5.7

21.52

71.62

u/ml

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

414

4150

1.00

0.01

1.6

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

3515

35154

1.00

0.00

34.9

23.1

135.59

136.34

g/l

2.09

3492

34771

(3016650) Hepatitis A virus Ab [Presence] in Serum

576

0.99

0.00

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

394

1.02

0.00

1.5

57.84

60.60

ug/l

0.15

394

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3515

35139

1.00

0.00

34.6

22.9

91.05

91.06

0.05

3494

34744

(3007461) Platelets [#/volume] in Blood

3514

35130

1.00

0.00

34.7

23.0

254.21

246.56

e9/l

9.21

3475

34424

(3035941) MCH [Entitic mass]

3515

35140

1.00

0.00

34.6

22.9

30.28

30.38

2.95

3494

34747

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

118

1.02

0.00

1.1

2.2

1.27

1.02

ug/l

0.15

108

(3026361) Erythrocytes [#/volume] in Blood

3515

35145

1.00

0.00

34.7

22.9

4.51

4.52

e12/l

0.45

3467

34327

(4268621) Lupus anticoagulant assay

360

1.00

0.00

2.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.02

0.00

1.3

1.1

960.00

838.10

titre

—

(3010813) Leukocytes [#/volume] in Blood

3516

35153

1.00

0.00

34.8

23.0

7.16

6.68

e9/l

27.30

3467

34328

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3515

35143

1.00

0.00

35.4

23.4

41.94

40.92

0.34

3489

34732

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

238

1.01

0.00

1.7

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

147

1465

1.00

0.00

1.5

1.4

22.64

24.70

iu/l

0.34

127

1263

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

2.98

—

(3018291) Platelet Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.4

—

2.43

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.2

—

1.28

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

0.89

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.2

—

7.40

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2629.86

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.0

—

4.37

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

0.27

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.3

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_BRONCH and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_BRONCH	1.698 [1.51, 1.91]	< 0.001
Birth year	0.996 [0.99, 1.0]	0.384

During the follow-up period (1.1.1998 — 31.12.2019), 1909 out of 5827 females with J10_BRONCH died.

Males

Parameter	HR [95% CI]	p-value
J10_BRONCH	2.105 [1.81, 2.44]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.007

During the follow-up period (1.1.1998 — 31.12.2019), 1998 out of 5250 males with J10_BRONCH died.

Mortality risk

Mortality risk for people of age

years, who have J10_BRONCH.

N-year risk	Females	Males
1	0.114%	0.399%
5	1.039%	2.452%
10	2.624%	6.119%
15	5.02%	11.305%
20	8.786%	18.783%

Relationships between endpoints

↥

Index endpoint: J10_BRONCH – Bronchitis, not specified as acute or chronic

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bronchitis, not specified as acute or chronic

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints